CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sulindac
Accession: CHEBI:9352
browse the term
Definition: A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions.
Synonyms: exact_synonym: {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
related_synonym: (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Clinoril; Formula=C20H17FO3S; InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-; InChIKey=MLKXDPUZXIRXEP-MFOYZWKCSA-N; SMILES=CC1=C(CC(O)=O)c2cc(F)ccc2C\\1=C/c1ccc(cc1)S(C)=O; Sulindacum; cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; sulindaco
xref: CAS:38194-50-2; DrugBank:DB00605; Drug_Central:2534; HMDB:HMDB0014743; KEGG:C01531; KEGG:D00120
xref_mesh: MESH:D013467
xref: PDBeChem:SUZ; PMID:11569947; PMID:11927004; PMID:12406542; PMID:15020200; PMID:15123337; PMID:19884509; PMID:23689354; PMID:23804703; Patent:DE2039426; Patent:US3654349; Reaxys:2951842; Wikipedia:Sulindac
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abcc1
ATP binding cassette subfamily C member 1
increases expression multiple interactions
ISO
Sulindac results in increased expression of ABCC1 protein Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein]
CTD
PMID:11820781
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC3 protein]
CTD
PMID:11820781
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
G
Abcd3
ATP binding cassette subfamily D member 3
increases expression
EXP
Sulindac results in increased expression of ABCD3 mRNA
CTD
PMID:24136188
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:209,852,087...209,906,020
G
Abhd16a
abhydrolase domain containing 16A, phospholipase
increases expression
EXP
Sulindac results in increased expression of ABHD16A mRNA
CTD
PMID:24136188
NCBI chr20:3,719,089...3,733,952
Ensembl chr20:3,719,091...3,733,927
G
Abi1
abl-interactor 1
decreases expression
EXP
Sulindac results in decreased expression of ABI1 mRNA
CTD
PMID:24136188
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
G
Acaca
acetyl-CoA carboxylase alpha
increases expression
ISO
Sulindac results in increased expression of ACACA mRNA
CTD
PMID:32535746
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acad9
acyl-CoA dehydrogenase family, member 9
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ACAD9 mRNA
CTD
PMID:20371263
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:118,943,174...118,966,547
G
Ace2
angiotensin converting enzyme 2
decreases expression
ISO EXP
Sulindac results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Acly
ATP citrate lyase
increases expression
ISO
Sulindac results in increased expression of ACLY mRNA
CTD
PMID:32535746
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,412,049...85,463,320
G
Acp2
acid phosphatase 2, lysosomal
increases expression
ISO
Sulindac results in increased expression of ACP2 mRNA
CTD
PMID:11906190
NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:77,175,895...77,185,680
G
Acsl1
acyl-CoA synthetase long-chain family member 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ACSL1 mRNA
CTD
PMID:20371263
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:45,755,254...45,821,541
G
Actr10
actin related protein 10
decreases expression
EXP
Sulindac results in decreased expression of ACTR10 mRNA
CTD
PMID:24136188
NCBI chr 6:89,446,141...89,472,350
Ensembl chr 6:89,446,093...89,473,047
G
Acy1
aminoacylase 1
increases expression
EXP
Sulindac results in increased expression of ACY1 mRNA
CTD
PMID:24136188
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Add1
adducin 1
increases expression
EXP
Sulindac results in increased expression of ADD1 mRNA
CTD
PMID:24136188
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ADHFE1 mRNA
CTD
PMID:20371263
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
G
Adipor2
adiponectin receptor 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ADIPOR2 mRNA
CTD
PMID:20371263
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adss2
adenylosuccinate synthase 2
increases expression
EXP
Sulindac results in increased expression of ADSS2 mRNA
CTD
PMID:24136188
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
G
Agfg2
ArfGAP with FG repeats 2
increases expression
EXP
Sulindac results in increased expression of CCZ1B mRNA
CTD
PMID:24136188
NCBI chr12:19,012,228...19,048,433
Ensembl chr12:19,012,258...19,048,421
G
Ahr
aryl hydrocarbon receptor
increases localization multiple interactions
ISO EXP
Sulindac results in increased localization of AHR protein Sulindac binds to and results in increased activity of AHR protein
CTD
PMID:16531450 PMID:17985343
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Aif1l
allograft inflammatory factor 1-like
decreases expression
ISO
Sulindac results in decreased expression of AIF1L mRNA
CTD
PMID:11906190
NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
affects localization
ISO
Sulindac affects the localization of AIFM1 protein
CTD
PMID:15946692 PMID:17136320
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Aifm2
AIF family member 2
increases expression
ISO
Sulindac results in increased expression of AIFM2 mRNA
CTD
PMID:11906190
NCBI chr20:29,654,283...29,679,239
Ensembl chr20:29,652,927...29,679,236
G
Akap1
A-kinase anchoring protein 1
increases expression
EXP
Sulindac results in increased expression of AKAP1 mRNA
CTD
PMID:24136188
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:73,621,883...73,653,896
G
Akap9
A-kinase anchoring protein 9
decreases expression
EXP
Sulindac results in decreased expression of AKAP9 mRNA
CTD
PMID:24136188
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akr1b1
aldo-keto reductase family 1 member B1
multiple interactions
ISO
Sulindac analog binds to and results in decreased activity of AKR1B1 protein; Sulindac binds to and results in decreased activity of AKR1B1 protein
CTD
PMID:25532697
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
multiple interactions
ISO
Sulindac analog binds to and results in decreased activity of AKR1B10 protein; Sulindac binds to and results in decreased activity of AKR1B10 protein
CTD
PMID:25532697
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
decreases activity
ISO
Sulindac results in decreased activity of AKR1C1 protein
CTD
PMID:19010312
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases activity
ISO
Sulindac results in decreased activity of AKR1C2 protein
CTD
PMID:19010312
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
Sulindac results in decreased activity of AKR1C3 protein
CTD
PMID:19010312
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Akt1
AKT serine/threonine kinase 1
multiple interactions decreases phosphorylation
ISO EXP
[AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein] Sulindac analog results in decreased phosphorylation of AKT1 protein [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of AKT1 mRNA
CTD
PMID:18924134 PMID:20371263
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt1s1
AKT1 substrate 1
decreases expression
EXP
Sulindac results in decreased expression of AKT1S1 mRNA
CTD
PMID:24136188
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
G
Akt2
AKT serine/threonine kinase 2
decreases expression increases expression
ISO EXP
Sulindac results in decreased expression of AKT2 mRNA Sulindac results in increased expression of AKT2 mRNA
CTD
PMID:11906190 PMID:24136188
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Alb
albumin
multiple interactions
EXP
[Sulindac co-treated with REN2] results in increased expression of ALB protein
CTD
PMID:12586211
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH1A1 mRNA
CTD
PMID:20371263
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH1L1 mRNA
CTD
PMID:20371263
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
EXP
Sulindac results in decreased expression of ALDH3A2 mRNA
CTD
PMID:24136188
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:45,908,524...45,949,281
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ALDH6A1 mRNA
CTD
PMID:20371263
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Alg14
ALG14, UDP-N-acetylglucosaminyltransferase subunit
increases expression
EXP
Sulindac results in increased expression of ALG14 mRNA
CTD
PMID:24136188
NCBI chr 2:209,368,285...209,445,425
Ensembl chr 2:209,368,312...209,445,431
G
Alox15
arachidonate 15-lipoxygenase
increases expression increases activity multiple interactions
ISO
Sulindac results in increased expression of ALOX15 protein Sulindac results in increased activity of ALOX15 protein [Sulindac results in increased expression of ALOX15 protein] which results in increased chemical synthesis of 13-hydroxy-9,11-octadecadienoic acid
CTD
PMID:10904086 PMID:11406566
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions
ISO
Sulindac promotes the reaction [cobaltous chloride results in decreased expression of ALPL protein]; Sulindac promotes the reaction [Deferoxamine results in decreased expression of ALPL protein]
CTD
PMID:21882223
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
G
Amd1
adenosylmethionine decarboxylase 1
multiple interactions
ISO
[Sulindac co-treated with Putrescine] results in decreased activity of AMD1 protein
CTD
PMID:17474863
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Amt
aminomethyltransferase
increases expression
EXP
Sulindac results in increased expression of AMT mRNA
CTD
PMID:24136188
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
G
Amz2
archaelysin family metallopeptidase 2
decreases expression
EXP
Sulindac results in decreased expression of AMZ2 mRNA
CTD
PMID:24136188
NCBI chr10:94,401,546...94,412,116
Ensembl chr10:94,401,579...94,412,114
G
Angptl3
angiopoietin-like 3
decreases expression
ISO
Sulindac results in decreased expression of ANGPTL3 mRNA
CTD
PMID:32535746
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Ankrd11
ankyrin repeat domain containing 11
increases expression
ISO
Sulindac results in increased expression of ANKRD11 mRNA
CTD
PMID:11906190
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
G
Ankrd24
ankyrin repeat domain 24
increases expression
EXP
Sulindac results in increased expression of ANKRD24 mRNA
CTD
PMID:24136188
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
G
Ankrd28
ankyrin repeat domain 28
decreases expression
EXP
Sulindac results in decreased expression of ANKRD28 mRNA
CTD
PMID:24136188
NCBI chr16:6,918,487...7,050,244
Ensembl chr16:6,914,336...7,050,249
G
Ankrd40
ankyrin repeat domain 40
increases expression
EXP
Sulindac results in increased expression of TMPRSS2 mRNA
CTD
PMID:32808185
NCBI chr10:79,282,075...79,295,322
Ensembl chr10:79,282,075...79,295,320 Ensembl chr10:79,282,075...79,295,320
G
Ap1ar
adaptor-related protein complex 1 associated regulatory protein
increases expression
EXP
Sulindac results in increased expression of AP1AR mRNA
CTD
PMID:24136188
NCBI chr 2:216,276,631...216,309,020
Ensembl chr 2:216,276,631...216,309,013
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
increases expression
EXP
Sulindac results in increased expression of AP3D1 mRNA
CTD
PMID:24136188
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:8,970,291...9,005,643
G
Apc
APC regulator of WNT signaling pathway
multiple interactions increases expression
EXP
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of APC mRNA] Sulindac results in increased expression of APC protein
CTD
PMID:11076880 PMID:12458338
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:25,864,222...25,922,696
G
Apob
apolipoprotein B
decreases secretion
ISO
Sulindac results in decreased secretion of APOB protein
CTD
PMID:32535746
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc3
apolipoprotein C3
decreases secretion
ISO
Sulindac results in decreased secretion of APOC3 protein
CTD
PMID:32535746
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
App
amyloid beta precursor protein
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA]
CTD
PMID:15190207
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Aqp1
aquaporin 1
decreases expression
EXP
Sulindac results in decreased expression of AQP1 mRNA
CTD
PMID:24136188
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
G
Arglu1
arginine and glutamate rich 1
increases expression
ISO
Sulindac results in increased expression of ARGLU1 mRNA
CTD
PMID:11906190
NCBI chr16:80,753,300...80,777,350
Ensembl chr16:80,753,315...80,777,349
G
Arid1b
AT-rich interaction domain 1B
decreases expression
EXP
Sulindac results in decreased expression of ARID1B mRNA
CTD
PMID:24136188
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
G
Arl1
ARF like GTPase 1
increases expression
EXP
Sulindac results in increased expression of ARL1 mRNA
CTD
PMID:24136188
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
G
Arrdc3
arrestin domain containing 3
increases expression
ISO
Sulindac results in increased expression of ARRDC3 mRNA
CTD
PMID:11906190
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
Sulindac results in increased expression of ASNS mRNA
CTD
PMID:11906190
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Asnsd1
asparagine synthetase domain containing 1
increases expression
EXP
Sulindac results in increased expression of ASNSD1 mRNA
CTD
PMID:24136188
NCBI chr 9:48,126,808...48,139,073
Ensembl chr 9:48,126,808...48,139,073
G
Ate1
arginyltransferase 1
decreases expression
EXP
Sulindac results in decreased expression of ATE1 mRNA
CTD
PMID:24136188
NCBI chr 1:184,961,548...185,081,112
Ensembl chr 1:184,963,562...185,080,908
G
Atf3
activating transcription factor 3
increases expression
ISO
Sulindac results in increased expression of ATF3 mRNA
CTD
PMID:11906190
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression
ISO
Sulindac results in increased expression of ATF4 mRNA
CTD
PMID:11906190
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atf6
activating transcription factor 6
increases expression
ISO
Sulindac results in increased expression of ATF6 mRNA
CTD
PMID:32535746
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg3
autophagy related 3
increases expression
EXP
Sulindac results in increased expression of ATG3 mRNA
CTD
PMID:24136188
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
decreases expression
ISO
Sulindac results in decreased expression of ATP2A1 mRNA
CTD
PMID:11906190
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838
G
Atp6v1a
ATPase H+ transporting V1 subunit A
increases expression
EXP
Sulindac results in increased expression of ATP6V1A mRNA
CTD
PMID:24136188
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:56,560,974...56,614,694
G
Atp6v1e1
ATPase H+ transporting V1 subunit E1
increases expression
EXP
Sulindac results in increased expression of ATP6V1E1 mRNA
CTD
PMID:24136188
NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:154,022,358...154,044,584
G
Auh
AU RNA binding methylglutaconyl-CoA hydratase
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of AUH mRNA
CTD
PMID:20371263
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
G
Aurka
aurora kinase A
decreases expression
ISO
Sulindac results in decreased expression of AURKA mRNA
CTD
PMID:11906190
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkaip1
aurora kinase A interacting protein 1
decreases expression
EXP
Sulindac results in decreased expression of AURKAIP1 mRNA
CTD
PMID:24136188
NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882
G
B4galt1
beta-1,4-galactosyltransferase 1
decreases expression
EXP
Sulindac results in decreased expression of B4GALT1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:55,935,615...55,982,461
G
Bad
BCL2-associated agonist of cell death
multiple interactions decreases expression
ISO
Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of BAD protein] Sulindac results in decreased expression of BAD protein
CTD
PMID:12566304
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
multiple interactions affects localization
ISO
SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein]
CTD
PMID:17136320
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases response to substance affects localization increases expression
ISO
SB 203580 inhibits the reaction [Sulindac affects the localization of BAX protein] BAX protein results in increased susceptibility to Sulindac Sulindac results in increased expression of BAX protein
CTD
PMID:11062132 PMID:17136320
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
Sulindac results in increased expression of BBC3 mRNA
CTD
PMID:11906190
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bcap29
B-cell receptor-associated protein 29
increases expression
ISO
Sulindac results in increased expression of BCAP29 mRNA
CTD
PMID:11906190
NCBI chr 6:48,182,702...48,222,698
Ensembl chr 6:48,182,706...48,222,720
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO EXP
Sulindac results in decreased expression of BCL2 protein [Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased cleavage of BCL2 protein [Olive Oil co-treated with Sulindac] results in decreased expression of BCL2 protein
CTD
PMID:10223192 PMID:15309441 PMID:15793875 PMID:17136320
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
ISO
[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein]; MAPK8 affects the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein] Sulindac results in decreased expression of BCL2L1 protein
CTD
PMID:11062132 PMID:18281123
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC2 protein
CTD
PMID:17136320
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC3 protein
CTD
PMID:17136320
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
[Sulindac co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 protein; [Sulindac co-treated with Vorinostat] results in decreased expression of BIRC5 mRNA; [Sulindac co-treated with Vorinostat] results in decreased expression of BIRC5 protein; [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC5 protein; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein modified form]; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein] Sulindac results in decreased expression of BIRC5 mRNA; Sulindac results in decreased expression of BIRC5 protein
CTD
PMID:11906190 PMID:14610217 PMID:17136320 PMID:17401459 PMID:18156316 PMID:18281123 More...
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Blmh
bleomycin hydrolase
increases expression
EXP
Sulindac results in increased expression of BLMH mRNA
CTD
PMID:24136188
NCBI chr10:61,772,112...61,815,212
Ensembl chr10:61,758,478...61,815,212
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
EXP
Sulindac results in increased expression of BNIP3L mRNA
CTD
PMID:24136188
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:41,174,594...41,197,803
G
Borcs7
BLOC-1 related complex subunit 7
increases expression
EXP
Sulindac results in increased expression of BORCS7 mRNA
CTD
PMID:24136188
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
G
Brca1
BRCA1, DNA repair associated
decreases expression
ISO
Sulindac results in decreased expression of BRCA1 mRNA
CTD
PMID:16273229
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brd4
bromodomain containing 4
decreases expression
ISO
Sulindac results in decreased expression of BRD4 mRNA
CTD
PMID:11906190
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,216,446...11,295,539
G
Btbd1
BTB domain containing 1
increases expression
EXP
Sulindac results in increased expression of BTBD1 mRNA
CTD
PMID:24136188
NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981
G
Bzw1
basic leucine zipper and W2 domains 1
increases expression
EXP
Sulindac results in increased expression of BZW1 mRNA
CTD
PMID:24136188
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
G
Bzw2
basic leucine zipper and W2 domains 2
decreases expression
ISO
Sulindac results in decreased expression of BZW2 mRNA
CTD
PMID:11093808
NCBI chr 6:58,555,362...58,615,921
Ensembl chr 6:52,827,661...52,888,628
G
C17h7orf25
similar to human chromosome 7 open reading frame 25
decreases expression
EXP
Sulindac results in decreased expression of C17H7ORF25 mRNA
CTD
PMID:24136188
NCBI chr17:50,543,231...50,549,880
Ensembl chr17:50,542,858...50,549,976
G
C18h18orf32
similar to human chromosome 18 open reading frame 32
decreases expression
EXP
Sulindac results in decreased expression of C18H18ORF32 mRNA
CTD
PMID:24136188
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
G
C1galt1c1
C1GALT1-specific chaperone 1
decreases expression
EXP
Sulindac results in decreased expression of C1GALT1C1 mRNA
CTD
PMID:24136188
NCBI chr X:122,243,736...122,248,217
Ensembl chr X:117,375,525...117,382,787
G
C2h1orf52
similar to human chromosome 1 open reading frame 52
increases expression
ISO
Sulindac results in increased expression of C1ORF52 mRNA
CTD
PMID:11906190
NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040
G
C4b
complement C4B
decreases expression
EXP
Sulindac results in decreased expression of C4B mRNA
CTD
PMID:24136188
NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,197,366...4,211,681
G
Calm3
calmodulin 3
decreases expression increases expression
ISO EXP
Sulindac results in decreased expression of CALM3 mRNA Sulindac results in increased expression of CALM3 mRNA
CTD
PMID:11906190 PMID:24136188
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
G
Car9
carbonic anhydrase 9
decreases expression
ISO
Sulindac analog results in decreased expression of CA9 mRNA
CTD
PMID:18924134
NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:57,763,206...57,769,838
G
Casp3
caspase 3
multiple interactions increases expression increases activity
ISO EXP
[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP3 protein] [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP3 protein Sulindac results in increased activity of CASP3 protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of CASP3 protein]
CTD
PMID:12017300 PMID:15713900 PMID:15946692 PMID:18281123 PMID:29999212
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
[Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein
CTD
PMID:21171083
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases activity increases expression
ISO
[Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein Sulindac results in increased activity of CASP9 protein [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein
CTD
PMID:15713900 PMID:18281123
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
decreases expression
EXP
Sulindac results in decreased expression of CAST mRNA
CTD
PMID:24136188
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cavin3
caveolae associated protein 3
increases expression
ISO
Sulindac results in increased expression of CAVIN3 mRNA
CTD
PMID:11906190
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]
CTD
PMID:16159934
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccna2
cyclin A2
decreases expression
ISO
Sulindac results in decreased expression of CCNA2 protein
CTD
PMID:16488075
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
Sulindac results in decreased expression of CCNB1 mRNA
CTD
PMID:11906190
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions decreases expression
ISO
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCND1 protein] [Sulindac co-treated with Plant Extracts] results in decreased expression of CCND1 protein
CTD
PMID:11504793 PMID:11593435 PMID:12351151 PMID:12584176 PMID:15020200 PMID:15489888 PMID:17292881 PMID:18291362 More...
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
decreases expression
ISO
Sulindac results in decreased expression of CCNE1 protein
CTD
PMID:16488075
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Ccnj
cyclin J
decreases expression
ISO
Sulindac results in decreased expression of CCNJ mRNA
CTD
PMID:11906190
NCBI chr 1:239,659,588...239,677,367
G
Ccnq
cyclin Q
decreases expression
EXP
Sulindac results in decreased expression of CCNQ mRNA
CTD
PMID:24136188
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
G
Cct4
chaperonin containing TCP1 subunit 4
decreases expression
EXP
Sulindac results in decreased expression of CCT4 mRNA
CTD
PMID:24136188
NCBI chr14:96,991,853...97,004,732
Ensembl chr14:96,991,859...97,005,267
G
Cdc37l1
cell division cycle 37-like 1
decreases expression
EXP
Sulindac results in decreased expression of CDC37L1 mRNA
CTD
PMID:24136188
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
G
Cdc42ep1
CDC42 effector protein 1
increases expression
ISO
Sulindac results in increased expression of CDC42EP1 mRNA
CTD
PMID:11906190
NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:110,395,332...110,403,200
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Sulindac results in decreased expression of CDK1 mRNA
CTD
PMID:16273229
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
multiple interactions decreases activity
ISO
Sulindac promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] Sulindac results in decreased activity of CDK2 protein
CTD
PMID:14566837
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
multiple interactions decreases expression
ISO EXP
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein] [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CDK4 mRNA
CTD
PMID:17292881 PMID:18291362 PMID:20371263
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Sulindac results in decreased expression of CDK6 protein
CTD
PMID:16488075
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions decreases activity increases activity increases expression increases response to substance
ISO EXP
[Sulindac co-treated with epigallocatechin gallate] results in increased expression of CDKN1A mRNA; CDKN1A protein promotes the reaction [Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein]; CSK protein affects the reaction [Sulindac results in increased expression of CDKN1A protein]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GBA1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GRN mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of IL32 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of ITGB3 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SAA1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SHC1 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA]; Sulindac inhibits the reaction [CDKN1A protein results in increased expression of TGM2 mRNA]; Sulindac promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] Sulindac results in decreased activity of CDKN1A protein Sulindac results in increased activity of CDKN1A protein Sulindac results in increased expression of CDKN1A mRNA; Sulindac results in increased expression of CDKN1A protein CDKN1A protein results in increased susceptibility to Sulindac [Azoxymethane co-treated with Sulindac] results in increased expression of CDKN1A protein
CTD
PMID:11507085 PMID:12628509 PMID:14566837 PMID:15190207 PMID:15688007 PMID:16230399 PMID:17292881 PMID:18291362 PMID:18644992 More...
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
EXP
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein]
CTD
PMID:12189186
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
multiple interactions
EXP
Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]
CTD
PMID:12189186
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Cep15
centrosomal protein 15
decreases expression
EXP
Sulindac results in decreased expression of CEP15 mRNA
CTD
PMID:24136188
NCBI chr15:12,815,159...12,835,115
Ensembl chr15:12,818,385...12,833,838
G
Cfl2
cofilin 2
decreases expression
EXP
Sulindac results in decreased expression of CFL2 mRNA
CTD
PMID:24136188
NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:72,355,664...72,359,674
G
Chchd3
coiled-coil-helix-coiled-coil-helix domain containing 3
decreases expression
EXP
Sulindac results in decreased expression of CHCHD3 mRNA
CTD
PMID:24136188
NCBI chr 4:61,360,352...61,616,850
Ensembl chr 4:61,360,353...61,616,847
G
Chchd5
coiled-coil-helix-coiled-coil-helix domain containing 5
increases expression
EXP
Sulindac results in increased expression of CHCHD5 mRNA
CTD
PMID:24136188
NCBI chr 3:116,361,845...116,372,238
Ensembl chr 3:116,361,885...116,367,169
G
Chd8
chromodomain helicase DNA binding protein 8
decreases expression
EXP
Sulindac results in decreased expression of CHD8 mRNA
CTD
PMID:24136188
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
G
Chmp2a
charged multivesicular body protein 2A
decreases expression
EXP
Sulindac results in decreased expression of CHMP2A mRNA
CTD
PMID:24136188
NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:73,660,046...73,662,452
G
Chrac1
chromatin accessibility complex subunit 1
increases expression
EXP
Sulindac results in increased expression of CHRAC1 mRNA
CTD
PMID:24136188
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
Sulindac inhibits the reaction [TNF protein results in increased activity of CHUK protein]
CTD
PMID:15489888
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Clpp
caseinolytic mitochondrial matrix peptidase proteolytic subunit
increases expression
EXP
Sulindac results in increased expression of CLPP mRNA
CTD
PMID:24136188
NCBI chr 9:1,831,680...1,837,700
Ensembl chr 9:1,830,311...1,837,693
G
Clu
clusterin
affects expression
ISO
Sulindac affects the expression of CLU protein
CTD
PMID:12388792
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
increases expression
EXP
Sulindac results in increased expression of CMTM6 mRNA
CTD
PMID:24136188
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
decreases expression
EXP
Sulindac results in decreased expression of CNGB1 mRNA
CTD
PMID:24136188
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
G
Cnnm4
cyclin and CBS domain divalent metal cation transport mediator 4
increases expression
ISO
Sulindac results in increased expression of CNNM4 mRNA
CTD
PMID:11906190
NCBI chr 9:38,711,726...38,750,942
Ensembl chr 9:38,711,710...38,750,942
G
Cnot6
CCR4-NOT transcription complex, subunit 6
decreases expression
EXP
Sulindac results in decreased expression of CNOT6 mRNA
CTD
PMID:24136188
NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025
G
Col1a2
collagen type I alpha 2 chain
increases expression
ISO
Sulindac results in increased expression of COL1A2 mRNA
CTD
PMID:18499699
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
G
Col5a2
collagen type V alpha 2 chain
increases expression
ISO
Sulindac results in increased expression of COL5A2 mRNA
CTD
PMID:18499699
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
Sulindac results in increased expression of COL6A2 mRNA
CTD
PMID:18499699
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,767...12,057,564
G
Col6a3
collagen type VI alpha 3 chain
increases expression
ISO
Sulindac results in increased expression of COL6A3 mRNA
CTD
PMID:18499699
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:91,361,583...91,439,471
G
Commd3
COMM domain containing 3
increases expression
EXP
Sulindac results in increased expression of COMMD3 mRNA
CTD
PMID:24136188
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
G
Commd5
COMM domain containing 5
increases expression
EXP
Sulindac results in increased expression of COMMD5 mRNA
CTD
PMID:24136188
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
G
Cops7a
COP9 signalosome subunit 7A
increases expression
EXP
Sulindac results in increased expression of COPS7A mRNA
CTD
PMID:24136188
NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:157,766,588...157,773,948
G
Cox15
cytochrome c oxidase assembly homolog COX15
increases expression
EXP
Sulindac results in increased expression of COX15 mRNA
CTD
PMID:24136188
NCBI chr 1:242,605,588...242,622,279
Ensembl chr 1:242,605,588...242,622,261
G
Cpne1
copine 1
decreases expression
ISO
Sulindac results in decreased expression of CPNE1 mRNA
CTD
PMID:11906190
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
G
Cpsf3
cleavage and polyadenylation specific factor 3
increases expression
EXP
Sulindac results in increased expression of CPSF3 mRNA
CTD
PMID:24136188
NCBI chr 6:46,564,855...46,592,776
Ensembl chr 6:40,836,097...40,864,128
G
Creb3l3
cAMP responsive element binding protein 3-like 3
increases expression
EXP
Sulindac results in increased expression of CREB3L3 mRNA
CTD
PMID:24136188
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Crebzf
CREB/ATF bZIP transcription factor
increases expression
EXP
Sulindac results in increased expression of CREBZF mRNA
CTD
PMID:24136188
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
G
Cry2
cryptochrome circadian regulator 2
decreases expression
EXP
Sulindac results in decreased expression of CRY2 mRNA
CTD
PMID:24136188
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:78,374,995...78,404,965
G
Csf1
colony stimulating factor 1
decreases expression
EXP
Sulindac results in decreased expression of CSF1 mRNA
CTD
PMID:24136188
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
G
Csk
C-terminal Src kinase
multiple interactions
ISO EXP
CSK protein affects the reaction [Sulindac results in increased expression of CDKN1A protein] [[Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein] which results in increased phosphorylation of and results in decreased activity of SRC protein; [Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein
CTD
PMID:18644992
NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:58,029,749...58,048,292
G
Csnk2a1
casein kinase 2 alpha 1
decreases expression increases expression
ISO EXP
Sulindac results in decreased expression of CSNK2A1 mRNA Sulindac results in increased expression of CSNK2A1 mRNA
CTD
PMID:11906190 PMID:24136188
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:140,709,991...140,756,696
G
Csnk2a2
casein kinase 2 alpha 2
increases expression
ISO
Sulindac results in increased expression of CSNK2A2 mRNA
CTD
PMID:11906190
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
G
Ctnnb1
catenin beta 1
multiple interactions decreases expression
ISO EXP
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein]; CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein]; CTNNB1 protein affects the reaction [Sulindac results in decreased expression of MYC protein]; Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein] Sulindac results in decreased expression of CTNNB1 protein [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein]
CTD
PMID:10223192 PMID:11751639 PMID:12351151 PMID:18291362 PMID:29999212
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA]
CTD
PMID:15190207
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Cxcl9
C-X-C motif chemokine ligand 9
multiple interactions
ISO
Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA]
CTD
PMID:17010317
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression increases activity decreases activity
ISO EXP
Sulindac results in increased expression of CYP1A1 mRNA Sulindac results in increased activity of CYP1A1 protein Sulindac results in decreased activity of CYP1A1 protein
CTD
PMID:16531450 PMID:17985343 PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression decreases expression
ISO EXP
Sulindac results in increased expression of CYP1A2 mRNA Sulindac results in decreased expression of CYP1A2 mRNA
CTD
PMID:16531450 PMID:17985343 PMID:24136188
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression increases activity decreases activity
ISO EXP
Sulindac results in increased expression of CYP1B1 mRNA Sulindac results in increased activity of CYP1B1 protein Sulindac results in decreased activity of CYP1B1 protein
CTD
PMID:16531450 PMID:17985343 PMID:33814510
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP2D4 mRNA
CTD
PMID:20371263
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP2J4 mRNA
CTD
PMID:20371263
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP4B1 mRNA
CTD
PMID:20371263
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of CYP8B1 mRNA
CTD
PMID:20371263
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Dcn
decorin
decreases expression
ISO
Sulindac results in decreased expression of DCN mRNA
CTD
PMID:11507085
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:32,281,252...32,321,270
G
Dctn5
dynactin subunit 5
decreases expression
EXP
Sulindac results in decreased expression of DCTN5 mRNA
CTD
PMID:24136188
NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:176,689,156...176,705,906
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
[Sulindac co-treated with epigallocatechin gallate] results in increased expression of DDIT3 mRNA Sulindac results in increased expression of DDIT3 mRNA
CTD
PMID:12628509 PMID:24136188
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddx1
DEAD-box helicase 1
decreases expression
EXP
Sulindac results in decreased expression of DDX1 mRNA
CTD
PMID:24136188
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
G
Degs1
delta(4)-desaturase, sphingolipid 1
increases expression
EXP
Sulindac results in increased expression of DEGS1 mRNA
CTD
PMID:24136188
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
G
Dffb
DNA fragmentation factor subunit beta
affects localization
ISO
Sulindac affects the localization of DFFB protein
CTD
PMID:15946692
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dhrs11
dehydrogenase/reductase 11
decreases activity
ISO
Sulindac results in decreased activity of DHRS11 protein
CTD
PMID:30926317
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
G
Dhx36
DEAH-box helicase 36
increases expression
EXP
Sulindac results in increased expression of DHX36 mRNA
CTD
PMID:24136188
NCBI chr 2:146,856,469...146,894,577
Ensembl chr 2:146,856,469...146,894,572
G
Dip2c
disco-interacting protein 2 homolog C
increases expression
EXP
Sulindac results in increased expression of DIP2C mRNA
CTD
PMID:24136188
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dlg1
discs large MAGUK scaffold protein 1
increases expression
EXP
Sulindac results in increased expression of DLG1 mRNA
CTD
PMID:24136188
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:68,911,883...69,102,689
G
Dnajc10
DnaJ heat shock protein family (Hsp40) member C10
increases expression
EXP
Sulindac results in increased expression of DNAJC10 mRNA
CTD
PMID:24136188
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
increases expression
EXP
Sulindac results in increased expression of DNAJC15 mRNA
CTD
PMID:24136188
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
G
Dpys
dihydropyrimidinase
increases expression
ISO
Sulindac results in increased expression of DPYS mRNA
CTD
PMID:11906190
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
G
Dynll1
dynein light chain LC8-type 1
decreases expression
EXP
Sulindac results in decreased expression of DYNLL1 mRNA
CTD
PMID:24136188
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
E2f1
E2F transcription factor 1
decreases expression
ISO
Sulindac results in decreased expression of E2F1 protein
CTD
PMID:16488075
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
Eci2
enoyl-CoA delta isomerase 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ECI2 mRNA
CTD
PMID:20371263
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
G
Egf
epidermal growth factor
multiple interactions
ISO
Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of BAD protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:12566304
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:218,219,415...218,302,064
G
Ehmt2
euchromatic histone lysine methyltransferase 2
decreases expression
ISO
Sulindac results in decreased expression of EHMT2 mRNA
CTD
PMID:11906190
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression
ISO
Sulindac results in increased expression of EIF2AK3 mRNA
CTD
PMID:32535746
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif5b
eukaryotic translation initiation factor 5B
increases expression
EXP
Sulindac results in increased expression of EIF5B mRNA
CTD
PMID:24136188
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
G
Elapor2
endosome-lysosome associated apoptosis and autophagy regulator family member 2
increases expression
ISO
Sulindac results in increased expression of ELAPOR2 mRNA
CTD
PMID:11906190
NCBI chr 4:24,613,163...24,805,729
Ensembl chr 4:24,613,163...24,805,729
G
Eloc
elongin C
increases expression
EXP
Sulindac results in increased expression of ELOC mRNA
CTD
PMID:24136188
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890 Ensembl chr20:2,661,724...2,677,890
G
Endog
endonuclease G
affects localization
ISO
Sulindac affects the localization of ENDOG protein
CTD
PMID:15946692
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Ercc5
ERCC excision repair 5, endonuclease
decreases expression
ISO
Sulindac results in decreased expression of ERCC5 mRNA
CTD
PMID:11906190
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
G
Ern1
endoplasmic reticulum to nucleus signaling 1
increases expression
ISO
Sulindac results in increased expression of ERN1 mRNA
CTD
PMID:32535746
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
EXP
Sulindac results in decreased expression of ERRFI1 mRNA
CTD
PMID:24136188
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Ess2
ess-2 splicing factor homolog
increases expression
ISO
Sulindac results in increased expression of ESS2 mRNA
CTD
PMID:11906190
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
G
Etfdh
electron transfer flavoprotein dehydrogenase
decreases expression
EXP
Sulindac results in decreased expression of ETFDH mRNA
CTD
PMID:24136188
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:164,729,749...164,762,745
G
Ets1
ETS proto-oncogene 1, transcription factor
increases expression
ISO
Sulindac results in increased expression of ETS1 mRNA
CTD
PMID:11906190
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:31,045,945...31,168,010
G
Exoc3
exocyst complex component 3
decreases expression
EXP
Sulindac results in decreased expression of EXOC3 mRNA
CTD
PMID:24136188
NCBI chr 1:30,919,871...30,950,624
Ensembl chr 1:29,091,294...29,122,045
G
Exoc7
exocyst complex component 7
increases expression
EXP
Sulindac results in increased expression of EXOC7 mRNA
CTD
PMID:24136188
NCBI chr10:102,019,805...102,039,333
Ensembl chr10:101,520,927...101,540,561
G
Exosc5
exosome component 5
decreases expression
EXP
Sulindac results in decreased expression of EXOSC5 mRNA
CTD
PMID:24136188
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
G
Exosc7
exosome component 7
decreases expression
EXP
Sulindac results in decreased expression of EXOSC7 mRNA
CTD
PMID:24136188
NCBI chr 8:122,773,607...122,798,943
Ensembl chr 8:122,773,591...122,799,270
G
Fam219b
family with sequence similarity 219, member B
decreases expression
EXP
Sulindac results in decreased expression of FAM219B mRNA
CTD
PMID:24136188
NCBI chr 8:57,941,327...57,946,916
Ensembl chr 8:57,941,294...57,946,906
G
Fam241b
family with sequence similarity 241 member B
increases expression
EXP
Sulindac results in increased expression of FAM241B mRNA
CTD
PMID:24136188
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084 Ensembl chr 6:30,052,324...30,055,084
G
Fasn
fatty acid synthase
increases expression
ISO
Sulindac results in increased expression of FASN mRNA
CTD
PMID:32535746
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fbxl4
F-box and leucine-rich repeat protein 4
increases expression
EXP
Sulindac results in increased expression of FBXL4 mRNA
CTD
PMID:24136188
NCBI chr 5:35,955,801...36,029,446
Ensembl chr 5:35,955,812...36,029,443
G
Fbxo42
F-box protein 42
increases expression
ISO
Sulindac results in increased expression of FBXO42 mRNA
CTD
PMID:11906190
NCBI chr 5:153,451,162...153,509,564
Ensembl chr 5:153,451,153...153,506,342
G
Fbxo6
F-box protein 6
decreases expression
EXP
Sulindac results in decreased expression of FBXO6 mRNA
CTD
PMID:24136188
NCBI chr 5:163,859,909...163,865,693
Ensembl chr 5:158,576,759...158,582,525
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
Sulindac results in increased expression of FHL2 mRNA
CTD
PMID:11906190
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fkbp1a
FKBP prolyl isomerase 1A
decreases expression
EXP
Sulindac results in decreased expression of FKBP1A mRNA
CTD
PMID:24136188
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:140,040,278...140,060,743
G
Fli1
Fli-1 proto-oncogene, ETS transcription factor
decreases expression
EXP
Sulindac results in decreased expression of FLI1 mRNA
CTD
PMID:24136188
NCBI chr 8:30,831,422...30,950,468
Ensembl chr 8:30,832,753...30,950,433
G
Flnb
filamin B
increases expression
EXP
Sulindac results in increased expression of FLNB mRNA
CTD
PMID:24136188
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:16,962,003...17,095,006
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
affects metabolic processing multiple interactions increases metabolic processing
ISO
FMO3 gene polymorphism affects the metabolism of Sulindac FMO3 gene polymorphism results in decreased metabolism of and results in increased susceptibility to Sulindac FMO3 protein results in increased metabolism of Sulindac
CTD
PMID:15623613 PMID:17050781
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Sulindac results in decreased expression of FOS protein
CTD
PMID:15020200
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fth1
ferritin heavy chain 1
increases expression
ISO
Sulindac results in increased expression of FTH1 mRNA
CTD
PMID:11093808
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
G
Ftl1
ferritin light chain 1
decreases expression
EXP
Sulindac results in decreased expression of FTL1 mRNA
CTD
PMID:24136188
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Fxn
frataxin
increases expression
EXP
Sulindac results in increased expression of FXN mRNA
CTD
PMID:24136188
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Sulindac results in increased expression of GADD45A mRNA
CTD
PMID:11906190
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gal
galanin and GMAP prepropeptide
affects expression
ISO
Sulindac affects the expression of GAL protein
CTD
PMID:12388792
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Galk1
galactokinase 1
increases expression
EXP
Sulindac results in increased expression of GALK1 mRNA
CTD
PMID:24136188
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
G
Gap43
growth associated protein 43
affects expression
ISO
Sulindac affects the expression of GAP43 protein
CTD
PMID:12388792
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gatad1
GATA zinc finger domain containing 1
increases expression
EXP
Sulindac results in increased expression of GATAD1 mRNA
CTD
PMID:24136188
NCBI chr 4:30,507,530...30,519,107
Ensembl chr 4:30,507,538...30,519,107
G
Gatad2a
GATA zinc finger domain containing 2A
increases expression
EXP
Sulindac results in increased expression of GATAD2A mRNA
CTD
PMID:24136188
NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
Sulindac results in decreased expression of GATD3 mRNA
CTD
PMID:11906190
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gba1
glucosylceramidase beta 1
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GBA1 mRNA]
CTD
PMID:15190207
NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:174,609,403...174,618,263
G
Gcdh
glutaryl-CoA dehydrogenase
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GCDH mRNA
CTD
PMID:20371263
NCBI chr19:40,168,038...40,174,536
Ensembl chr19:23,263,264...23,269,681
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions affects expression increases expression
ISO
Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein] Sulindac affects the expression of GCLC mRNA
CTD
PMID:11820781 PMID:15946948
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
increases expression
ISO
Sulindac results in increased expression of GCNT1 mRNA
CTD
PMID:11093808
NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:214,718,293...214,758,776
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Sulindac results in increased expression of GDF15 mRNA; Sulindac results in increased expression of GDF15 protein
CTD
PMID:11906190 PMID:11984525 PMID:15180942
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Ghitm
growth hormone inducible transmembrane protein
increases expression
EXP
Sulindac results in increased expression of GHITM mRNA
CTD
PMID:24136188
NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,885,553...12,897,879
G
Ghr
growth hormone receptor
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GHR mRNA
CTD
PMID:20371263
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:52,542,594...52,804,735
G
Glo1
glyoxalase 1
decreases activity
ISO
Sulindac results in decreased activity of GLO1 protein
CTD
PMID:17243824
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Gnas
GNAS complex locus
increases expression
EXP
Sulindac results in increased expression of GNAS mRNA
CTD
PMID:24136188
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnl3l
G protein nucleolar 3 like
decreases expression
EXP
Sulindac results in decreased expression of GNL3L mRNA
CTD
PMID:24136188
NCBI chr X:19,961,277...19,994,454
Ensembl chr X:19,958,603...19,994,508
G
Gnmt
glycine N-methyltransferase
decreases expression
EXP
Sulindac results in decreased expression of GNMT mRNA
CTD
PMID:24136188
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
G
Gpx3
glutathione peroxidase 3
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GPX3 mRNA
CTD
PMID:20371263
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
Sulindac results in increased expression of GRB10 mRNA
CTD
PMID:11906190
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:86,495,054...86,602,806
G
Grb2
growth factor receptor bound protein 2
increases expression
EXP
Sulindac results in increased expression of GRB2 mRNA
CTD
PMID:24136188
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
affects expression
EXP
Sulindac affects the expression of GRIN1 protein
CTD
PMID:15123337
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
affects expression
EXP
Sulindac affects the expression of GRIN2B protein
CTD
PMID:15123337
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Grk6
G protein-coupled receptor kinase 6
decreases expression
EXP
Sulindac results in decreased expression of GRK6 mRNA
CTD
PMID:24136188
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,177,019...9,192,644
G
Grn
granulin precursor
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GRN mRNA]
CTD
PMID:15190207
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsk3b
glycogen synthase kinase 3 beta
decreases phosphorylation
ISO
Sulindac results in decreased phosphorylation of GSK3B protein
CTD
PMID:11593435
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gstm2
glutathione S-transferase mu 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GSTM2 mRNA
CTD
PMID:20371263
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstt1
glutathione S-transferase theta 1
increases expression
EXP
Sulindac results in increased expression of GSTT1 protein
CTD
PMID:9729437
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gtf2b
general transcription factor IIB
increases expression decreases expression
ISO EXP
Sulindac results in increased expression of GTF2B mRNA Sulindac results in decreased expression of GTF2B mRNA
CTD
PMID:11906190 PMID:24136188
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[Arsenic Trioxide co-treated with Sulindac] results in increased phosphorylation of H2AX protein
CTD
PMID:18636201
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
H2az1
H2A.Z variant histone 1
increases expression
EXP
Sulindac results in increased expression of H2AZ1 mRNA
CTD
PMID:24136188
NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
decreases expression
EXP
Sulindac results in decreased expression of HADHB mRNA
CTD
PMID:24136188
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:26,153,578...26,184,869
G
Helz2
helicase with zinc finger 2
decreases expression
EXP
Sulindac results in decreased expression of HELZ2 mRNA
CTD
PMID:24136188
NCBI chr 3:188,716,370...188,730,776
Ensembl chr 3:168,338,813...168,353,159
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Sulindac results in increased expression of HERPUD1 mRNA
CTD
PMID:11093808
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,598,417...10,618,424
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions decreases expression
ISO
[AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein]] which affects the susceptibility to Oxygen; AKT1 protein affects the reaction [Sulindac analog results in decreased expression of HIF1A protein] Sulindac analog results in decreased expression of HIF1A mRNA; Sulindac analog results in decreased expression of HIF1A protein
CTD
PMID:18924134
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Higd1a
HIG1 hypoxia inducible domain family, member 1A
increases expression
EXP
Sulindac results in increased expression of HIGD1A mRNA
CTD
PMID:24136188
NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:121,514,156...121,523,443
G
Hlcs
holocarboxylase synthetase
decreases expression
ISO
Sulindac results in decreased expression of HLCS mRNA
CTD
PMID:11906190
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
G
Hmgb3
high mobility group box 3
increases expression
EXP
Sulindac results in increased expression of HMGB3 mRNA
CTD
PMID:24136188
NCBI chr X:154,341,106...154,346,087
Ensembl chr X:149,296,375...149,301,292
G
Hmmr
hyaluronan-mediated motility receptor
decreases expression
ISO
Sulindac results in decreased expression of HMMR mRNA
CTD
PMID:11906190
NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,132,977...25,163,060
G
Hmox1
heme oxygenase 1
multiple interactions decreases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; pyrazolanthrone inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; SB 203580 inhibits the reaction [Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein]]; Sulindac promotes the reaction [arsenic trioxide results in increased expression of HMOX1 protein] Sulindac results in decreased expression of HMOX1 protein
CTD
PMID:18636201
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnf4a
hepatocyte nuclear factor 4, alpha
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of HNF4A mRNA
CTD
PMID:20371263
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of HSD17B4 mRNA
CTD
PMID:20371263
NCBI chr18:45,515,427...45,604,467
Ensembl chr18:43,328,824...43,417,952
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
Sulindac results in increased activity of HSF1 protein
CTD
PMID:10328874
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Hspa9
heat shock protein family A (Hsp70) member 9
increases expression
EXP
Sulindac results in increased expression of HSPA9 mRNA
CTD
PMID:24136188
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
G
Icam1
intercellular adhesion molecule 1
decreases expression
ISO
Sulindac results in decreased expression of ICAM1 protein
CTD
PMID:18059344
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifi27
interferon, alpha-inducible protein 27
decreases expression
EXP
Sulindac results in decreased expression of IFI27 mRNA
CTD
PMID:24136188
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifitm3
interferon induced transmembrane protein 3
decreases expression
EXP
Sulindac results in decreased expression of IFITM3 mRNA
CTD
PMID:24136188
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifnar1
interferon alpha and beta receptor subunit 1
decreases expression
EXP
Sulindac results in decreased expression of IFNAR1 mRNA
CTD
PMID:24136188
NCBI chr11:44,211,769...44,238,206
Ensembl chr11:30,725,790...30,749,979
G
Ifng
interferon gamma
multiple interactions
ISO
Sulindac inhibits the reaction [IFNG protein results in increased expression of CXCL9 mRNA]
CTD
PMID:17010317
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Iftap
intraflagellar transport associated protein
increases expression
EXP
Sulindac results in increased expression of IFTAP mRNA
CTD
PMID:24136188
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases activity
ISO
Sulindac results in decreased activity of IKBKB protein
CTD
PMID:19526344
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il11ra1
interleukin 11 receptor subunit alpha 1
increases expression
EXP
Sulindac results in increased expression of IL11RA1 mRNA
CTD
PMID:24136188
NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:56,935,516...56,941,408
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IL1A mRNA
CTD
PMID:20371263
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions decreases expression increases expression
ISO EXP
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of IL1B mRNA; Sulindac inhibits the reaction [IL1B protein results in increased abundance of Hyaluronic Acid]; Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA] Sulindac results in decreased expression of IL1B mRNA Sulindac results in decreased expression of IL1B protein Sulindac results in increased expression of IL1B
CTD
PMID:10328874 PMID:11318944 PMID:12628509 PMID:15123337 PMID:16159934 PMID:24136188 More...
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
multiple interactions increases expression
ISO
Sulindac promotes the reaction [IL24 protein results in increased phosphorylation of MAPK8 protein] [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP3 protein; [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein; Sulindac results in increased expression of IL24 protein
CTD
PMID:15713900
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:42,353,090...42,358,487
G
Il6
interleukin 6
multiple interactions increases expression
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IL6 mRNA Sulindac results in increased expression of IL6
CTD
PMID:20371263 PMID:24136188
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ilk
integrin-linked kinase
decreases activity
ISO
Sulindac results in decreased activity of ILK protein
CTD
PMID:11593435
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Inpp5e
inositol polyphosphate-5-phosphatase E
increases expression
ISO
Sulindac results in increased expression of INPP5E mRNA
CTD
PMID:11906190
NCBI chr 3:9,216,776...9,229,539
Ensembl chr 3:9,216,776...9,229,450
G
Ipmk
inositol polyphosphate multikinase
decreases expression
EXP
Sulindac results in decreased expression of IPMK mRNA
CTD
PMID:24136188
NCBI chr20:17,216,988...17,251,675
Ensembl chr20:17,218,037...17,251,705
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of IRAK2 mRNA
CTD
PMID:20371263
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:146,786,100...146,842,602
G
Irf7
interferon regulatory factor 7
decreases expression
EXP
Sulindac results in decreased expression of IRF7 mRNA
CTD
PMID:24136188
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Isca1
iron-sulfur cluster assembly 1
decreases expression
EXP
Sulindac results in decreased expression of ISCA1 mRNA
CTD
PMID:24136188
NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,905,287...4,917,955
G
Itga2
integrin subunit alpha 2
increases expression
ISO
Sulindac results in increased expression of ITGA2 mRNA
CTD
PMID:11906190
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itgb3
integrin subunit beta 3
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of ITGB3 mRNA]
CTD
PMID:15190207
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Itgb4
integrin subunit beta 4
multiple interactions
ISO
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of ITGB4 mRNA
CTD
PMID:12628509
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Jkamp
JNK1/MAPK8-associated membrane protein
decreases expression
EXP
Sulindac results in decreased expression of JKAMP mRNA
CTD
PMID:24136188
NCBI chr 6:90,648,043...90,661,985
Ensembl chr 6:90,648,160...90,662,501
G
Josd1
Josephin domain containing 1
decreases expression
EXP
Sulindac results in decreased expression of JOSD1 mRNA
CTD
PMID:24136188
NCBI chr 7:113,110,709...113,124,632
Ensembl chr 7:111,230,318...111,244,652
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions
ISO
Sulindac results in decreased expression of JUN protein [Sulindac co-treated with Plant Extracts] results in decreased expression of JUN protein
CTD
PMID:12351151 PMID:12584176
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Sulindac results in increased expression of JUND mRNA
CTD
PMID:11906190
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Kcnh3
potassium voltage-gated channel subfamily H member 3
decreases expression
EXP
Sulindac results in decreased expression of KCNH3 mRNA
CTD
PMID:24136188
NCBI chr 7:130,365,593...130,383,859
Ensembl chr 7:130,366,011...130,383,855
G
Kctd5
potassium channel tetramerization domain containing 5
increases expression
EXP
Sulindac results in increased expression of KCTD5 mRNA
CTD
PMID:24136188
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
G
Keap1
Kelch-like ECH-associated protein 1
decreases expression
EXP
Sulindac results in decreased expression of KEAP1 mRNA
CTD
PMID:24136188
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Khsrp
KH-type splicing regulatory protein
increases expression
EXP
Sulindac results in increased expression of KHSRP mRNA
CTD
PMID:24136188
NCBI chr 9:1,862,555...1,872,403
Ensembl chr 9:1,862,899...1,872,451
G
Kif14
kinesin family member 14
increases expression
ISO
Sulindac results in increased expression of KIF14 mRNA
CTD
PMID:11906190
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:47,927,044...47,989,164
G
Klf5
KLF transcription factor 5
increases expression
ISO
Sulindac results in increased expression of KLF5 mRNA
CTD
PMID:11906190
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Kras
KRAS proto-oncogene, GTPase
affects response to substance
ISO
KRAS protein affects the susceptibility to Sulindac
CTD
PMID:11751493
NCBI chr 4:179,916,255...179,949,613
G
Lad1
ladinin 1
increases expression
ISO
Sulindac results in increased expression of LAD1 mRNA
CTD
PMID:11507085
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
G
Lamtor4
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
decreases expression
EXP
Sulindac results in decreased expression of LAMTOR4 mRNA
CTD
PMID:24136188
NCBI chr12:17,258,656...17,262,478
Ensembl chr12:17,258,623...17,262,480
G
Larp1b
La ribonucleoprotein 1B
decreases expression
EXP
Sulindac results in decreased expression of LARP1B mRNA
CTD
PMID:24136188
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Larp4
La ribonucleoprotein 4
increases expression
ISO
Sulindac results in increased expression of LARP4 mRNA
CTD
PMID:11906190
NCBI chr 7:131,104,470...131,152,692
Ensembl chr 7:131,101,564...131,150,811
G
Lbp
lipopolysaccharide binding protein
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of LBP mRNA
CTD
PMID:20371263
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Ldb1
LIM domain binding 1
increases expression
ISO
Sulindac results in increased expression of LDB1 mRNA
CTD
PMID:11906190
NCBI chr 1:254,813,161...254,838,931
Ensembl chr 1:244,877,173...244,890,013
G
Lef1
lymphoid enhancer binding factor 1
multiple interactions
ISO
Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein]
CTD
PMID:11751639
NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:219,666,592...219,779,794
G
Lfng
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Sulindac results in increased expression of LFNG mRNA
CTD
PMID:11906190
NCBI chr12:19,144,474...19,152,951
Ensembl chr12:14,018,333...14,039,008
G
Lgals3
galectin 3
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA]
CTD
PMID:15190207
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025
G
Lgals3bp
galectin 3 binding protein
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA]
CTD
PMID:15190207
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lipe
lipase E, hormone sensitive type
decreases expression
EXP
Sulindac results in decreased expression of LIPE mRNA
CTD
PMID:24136188
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:80,965,627...80,984,310
G
Litaf
lipopolysaccharide-induced TNF factor
increases expression
EXP
Sulindac results in increased expression of LITAF mRNA
CTD
PMID:24136188
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:4,625,552...4,692,763
G
Lmf2
lipase maturation factor 2
decreases expression
EXP
Sulindac results in decreased expression of LMF2 mRNA
CTD
PMID:24136188
NCBI chr 7:120,418,343...120,422,825
Ensembl chr 7:120,418,345...120,422,823
G
Lonp1
lon peptidase 1, mitochondrial
decreases expression
EXP
Sulindac results in decreased expression of LONP1 mRNA
CTD
PMID:24136188
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lox
lysyl oxidase
decreases expression
ISO
Sulindac analog results in decreased expression of LOX mRNA
CTD
PMID:18924134
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Lrpprc
leucine-rich pentatricopeptide repeat containing
decreases expression
EXP
Sulindac results in decreased expression of LRPPRC mRNA
CTD
PMID:24136188
NCBI chr 6:9,859,816...9,942,294
Ensembl chr 6:9,859,867...9,942,293
G
Lsm10
LSM10, U7 small nuclear RNA associated
increases expression
EXP
Sulindac results in increased expression of LSM10 mRNA
CTD
PMID:24136188
NCBI chr 5:143,649,817...143,660,391
Ensembl chr 5:138,373,119...138,377,505
G
Lsm12
LSM12 homolog
increases expression
EXP
Sulindac results in increased expression of LSM12 mRNA
CTD
PMID:24136188
NCBI chr10:87,118,334...87,140,395
Ensembl chr10:87,118,416...87,140,396
G
Lsm6
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
EXP
Sulindac results in increased expression of LSM6 mRNA
CTD
PMID:24136188
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
G
Macroh2a1
macroH2A.1 histone
decreases expression
EXP
Sulindac results in decreased expression of MACROH2A1 mRNA
CTD
PMID:24136188
NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,479,372...8,542,072
G
Maoa
monoamine oxidase A
decreases expression
EXP
Sulindac results in decreased expression of MAOA mRNA
CTD
PMID:24136188
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593
G
Maob
monoamine oxidase B
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAOB mRNA
CTD
PMID:20371263
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:5,907,266...6,011,003
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAP3K8 mRNA
CTD
PMID:20371263
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216
G
Map4k3
mitogen-activated protein kinase kinase kinase kinase 3
increases expression
ISO
Sulindac results in increased expression of MAP4K3 mRNA
CTD
PMID:11906190
NCBI chr 6:20,029,246...20,198,583
Ensembl chr 6:14,277,121...14,446,334
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO EXP
[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK1 protein; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK1 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein] [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MAPK1 mRNA
CTD
PMID:12566304 PMID:18281123 PMID:18636201 PMID:20371263
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO
[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK3 protein; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK3 protein]; Sulindac inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:12566304 PMID:18281123 PMID:18636201
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases expression increases phosphorylation
ISO
CDKN1A protein promotes the reaction [Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein]; MAPK8 affects the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; Sulindac promotes the reaction [IL24 protein results in increased phosphorylation of MAPK8 protein]; Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein; Sulindac results in increased phosphorylation of and results in increased activity of MAPK8 protein Sulindac results in increased expression of MAPK8 mRNA Sulindac results in increased phosphorylation of MAPK8 protein
CTD
PMID:15713900 PMID:17292881 PMID:18281123
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mark3
microtubule affinity regulating kinase 3
decreases expression
EXP
Sulindac results in decreased expression of MARK3 mRNA
CTD
PMID:24136188
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
G
Mbd2
methyl-CpG binding domain protein 2
decreases expression
EXP
Sulindac results in decreased expression of MBD2 mRNA
CTD
PMID:24136188
NCBI chr18:66,449,196...66,516,112
Ensembl chr18:64,174,002...64,240,794
G
Mbd3
methyl-CpG binding domain protein 3
decreases expression
EXP
Sulindac results in decreased expression of MBD3 mRNA
CTD
PMID:24136188
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Me1
malic enzyme 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ME1 mRNA
CTD
PMID:20371263
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med10
mediator complex subunit 10
increases expression
EXP
Sulindac results in increased expression of MED10 mRNA
CTD
PMID:24136188
NCBI chr 1:33,470,064...33,481,698
Ensembl chr 1:33,470,066...33,475,767
G
Med15
mediator complex subunit 15
increases expression
ISO
Sulindac results in increased expression of MED15 mRNA
CTD
PMID:11906190
NCBI chr11:83,280,722...83,356,006
Ensembl chr11:83,280,762...83,355,362
G
Mesd
mesoderm development LRP chaperone
decreases expression
EXP
Sulindac results in decreased expression of MESD mRNA
CTD
PMID:24136188
NCBI chr 1:137,866,707...137,879,999
Ensembl chr 1:137,874,242...137,879,999
G
Mettl23
methyltransferase 23, arginine
increases expression
EXP
Sulindac results in increased expression of METTL23 mRNA
CTD
PMID:24136188
NCBI chr10:102,047,090...102,053,379
Ensembl chr10:102,047,314...102,051,977
G
Mfap3
microfibril associated protein 3
decreases expression
EXP
Sulindac results in decreased expression of MFAP3 mRNA
CTD
PMID:24136188
NCBI chr10:41,696,788...41,711,490
Ensembl chr10:41,696,771...41,710,406
G
Mff
mitochondrial fission factor
decreases expression
EXP
Sulindac results in decreased expression of MFF mRNA
CTD
PMID:24136188
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
G
Mgst2
microsomal glutathione S-transferase 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MGST2 mRNA
CTD
PMID:20371263
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mgst3
microsomal glutathione S-transferase 3
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MGST3 mRNA
CTD
PMID:20371263
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
G
Miip
migration and invasion inhibitory protein
increases expression
ISO
Sulindac results in increased expression of MIIP mRNA
CTD
PMID:11906190
NCBI chr 5:158,292,510...158,299,533
Ensembl chr 5:158,292,511...158,299,694
G
Mllt6
MLLT6, PHD finger containing
decreases expression
EXP
Sulindac results in decreased expression of MLLT6 mRNA
CTD
PMID:24136188
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
G
Mmp14
matrix metallopeptidase 14
decreases expression
EXP
Sulindac results in decreased expression of MMP14 mRNA
CTD
PMID:24136188
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
Sulindac results in decreased expression of MMP7 mRNA; Sulindac results in decreased expression of MMP7 protein
CTD
PMID:18499699
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Mogs
mannosyl-oligosaccharide glucosidase
decreases expression
EXP
Sulindac results in decreased expression of MOGS mRNA
CTD
PMID:24136188
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
G
Mrpl1
mitochondrial ribosomal protein L1
decreases expression
EXP
Sulindac results in decreased expression of MRPL1 mRNA
CTD
PMID:24136188
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
G
Mrpl11
mitochondrial ribosomal protein L11
decreases expression
EXP
Sulindac results in decreased expression of MRPL11 mRNA
CTD
PMID:24136188
NCBI chr 1:211,693,807...211,696,667
Ensembl chr 1:202,264,471...202,267,756
G
Mrpl13
mitochondrial ribosomal protein L13
increases expression
EXP
Sulindac results in increased expression of MRPL13 mRNA
CTD
PMID:24136188
NCBI chr 7:86,951,541...86,973,147
Ensembl chr 7:86,951,541...86,973,577
G
Mrpl17
mitochondrial ribosomal protein L17
decreases expression
EXP
Sulindac results in decreased expression of MRPL17 mRNA
CTD
PMID:24136188
NCBI chr 1:160,162,181...160,163,870
Ensembl chr 1:160,158,807...160,163,815
G
Mrpl20
mitochondrial ribosomal protein L20
decreases expression
EXP
Sulindac results in decreased expression of MRPL20 mRNA
CTD
PMID:24136188
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
G
Mrpl22
mitochondrial ribosomal protein L22
increases expression
EXP
Sulindac results in increased expression of MRPL22 mRNA
CTD
PMID:24136188
NCBI chr10:42,345,446...42,355,779
Ensembl chr10:42,342,776...42,355,779
G
Mrpl23
mitochondrial ribosomal protein L23
decreases expression
EXP
Sulindac results in decreased expression of MRPL23 mRNA
CTD
PMID:24136188
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
G
Mrpl32
mitochondrial ribosomal protein L32
increases expression
EXP
Sulindac results in increased expression of MRPL32 mRNA
CTD
PMID:24136188
NCBI chr17:50,565,133...50,568,000
Ensembl chr17:50,565,055...50,568,010
G
Mrpl37
mitochondrial ribosomal protein L37
decreases expression
EXP
Sulindac results in decreased expression of MRPL37 mRNA
CTD
PMID:24136188
NCBI chr 5:121,827,892...121,846,187
Ensembl chr 5:121,829,111...121,846,176
G
Mrpl53
mitochondrial ribosomal protein L53
increases expression
EXP
Sulindac results in increased expression of MRPL53 mRNA
CTD
PMID:24136188
NCBI chr 4:115,615,329...115,616,219
G
Mrpl54
mitochondrial ribosomal protein L54
increases expression
EXP
Sulindac results in increased expression of MRPL54 mRNA
CTD
PMID:24136188
NCBI chr 7:8,452,801...8,455,321
Ensembl chr 7:8,452,716...8,455,321
G
Mrpl58
mitochondrial ribosomal protein L58
decreases expression
EXP
Sulindac results in decreased expression of MRPL58 mRNA
CTD
PMID:24136188
NCBI chr10:100,646,374...100,652,871
Ensembl chr10:100,646,216...100,652,871
G
Mrps14
mitochondrial ribosomal protein S14
decreases expression
EXP
Sulindac results in decreased expression of MRPS14 mRNA
CTD
PMID:24136188
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
G
Mrps24
mitochondrial ribosomal protein S24
decreases expression
EXP
Sulindac results in decreased expression of MRPS24 mRNA
CTD
PMID:24136188
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
G
Mrps31
mitochondrial ribosomal protein S31
decreases expression
EXP
Sulindac results in decreased expression of MRPS31 mRNA
CTD
PMID:24136188
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
G
Mrps33
mitochondrial ribosomal protein S33
increases expression
EXP
Sulindac results in increased expression of MRPS33 mRNA
CTD
PMID:24136188
NCBI chr 4:68,596,729...68,605,547
Ensembl chr 4:68,596,729...68,605,428
G
Mrps7
mitochondrial ribosomal protein S7
decreases expression
EXP
Sulindac results in decreased expression of MRPS7 mRNA
CTD
PMID:24136188
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
G
Mrps9
mitochondrial ribosomal protein S9
increases expression
EXP
Sulindac results in increased expression of MRPS9 mRNA
CTD
PMID:24136188
NCBI chr 9:45,113,554...45,172,375
Ensembl chr 9:45,113,554...45,172,375
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
ISO
Sulindac results in increased expression of MTHFD2 mRNA
CTD
PMID:11906190
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Mtpn
myotrophin
increases expression
EXP
Sulindac results in increased expression of MTPN mRNA
CTD
PMID:24136188
NCBI chr 4:64,159,273...64,186,686
Ensembl chr 4:64,157,641...64,186,724
G
Mttp
microsomal triglyceride transfer protein
increases expression
ISO
Sulindac results in increased expression of MTTP mRNA
CTD
PMID:32535746
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Mug1
murinoglobulin 1
decreases expression
EXP
Sulindac results in decreased expression of MUG1 mRNA
CTD
PMID:24136188
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions increases expression decreases expression
ISO EXP
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of MYC protein] Sulindac results in increased expression of MYC mRNA Sulindac inhibits the reaction [Azoxymethane results in increased expression of MYC mRNA]; Sulindac inhibits the reaction [Azoxymethane results in increased expression of MYC protein]
CTD
PMID:12189186 PMID:12414619 PMID:17292881 PMID:18291362
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Mzf1
myeloid zinc finger 1
decreases expression
EXP
Sulindac results in decreased expression of MZF1 mRNA
CTD
PMID:24136188
NCBI chr 1:73,670,522...73,682,885
Ensembl chr 1:73,670,541...73,681,635
G
Naa35
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
decreases expression
EXP
Sulindac results in decreased expression of NAA35 mRNA
CTD
PMID:24136188
NCBI chr17:5,034,360...5,086,456
Ensembl chr17:5,034,356...5,086,386
G
Nampt
nicotinamide phosphoribosyltransferase
decreases expression
EXP
Sulindac results in decreased expression of NAMPT mRNA
CTD
PMID:24136188
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Nap1l1
nucleosome assembly protein 1-like 1
decreases expression
ISO
Sulindac results in decreased expression of NAP1L1 mRNA
CTD
PMID:11507085
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Nat1
N-acetyltransferase 1
decreases expression
ISO
Sulindac results in decreased expression of NAT1 mRNA
CTD
PMID:11828994
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:22,208,194...22,238,520
G
Ndrg1
N-myc downstream regulated 1
increases expression decreases expression
ISO EXP
Sulindac results in increased expression of NDRG1 mRNA Sulindac results in decreased expression of NDRG1 mRNA
CTD
PMID:16273229 PMID:24136188
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Ndst2
N-deacetylase and N-sulfotransferase 2
decreases expression
ISO
Sulindac results in decreased expression of NDST2 mRNA
CTD
PMID:11906190
NCBI chr15:3,563,515...3,573,801
Ensembl chr15:3,563,358...3,573,801
G
Ndufa5
NADH:ubiquinone oxidoreductase subunit A5
increases expression
EXP
Sulindac results in increased expression of NDUFA5 mRNA
CTD
PMID:24136188
NCBI chr 4:53,962,877...53,971,235
Ensembl chr 4:52,995,546...53,005,598 Ensembl chr 5:52,995,546...53,005,598
G
Ndufv3
NADH:ubiquinone oxidoreductase subunit V3
increases expression
EXP
Sulindac results in increased expression of NDUFV3 mRNA
CTD
PMID:24136188
NCBI chr20:9,613,786...9,622,941
Ensembl chr20:9,612,431...9,623,074 Ensembl chr13:9,612,431...9,623,074
G
Nek7
NIMA-related kinase 7
decreases expression
EXP
Sulindac results in decreased expression of NEK7 mRNA
CTD
PMID:24136188
NCBI chr13:50,022,212...50,149,374
Ensembl chr13:50,022,218...50,149,296
G
Neu1
neuraminidase 1
increases expression
ISO
Sulindac results in increased expression of NEU1 mRNA
CTD
PMID:11906190
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
G
Nfe2l1
NFE2 like bZIP transcription factor 1
increases expression
ISO EXP
Sulindac results in increased expression of NFE2L1 mRNA
CTD
PMID:11906190 PMID:24136188
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:81,800,366...81,832,318
G
Nfib
nuclear factor I/B
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFIB mRNA
CTD
PMID:20371263
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
ISO
Sulindac results in increased expression of NFIL3 mRNA
CTD
PMID:11906190
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,280,484...12,295,858
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions decreases activity
ISO
Acetylcysteine inhibits the reaction [Sulindac analog results in decreased activity of NFKB1 protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]
CTD
PMID:15489888 PMID:18922898
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions decreases phosphorylation
ISO EXP
[[Sulindac co-treated with arsenic trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; [Sulindac co-treated with arsenic trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein; Sulindac inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Sulindac results in increased degradation of and results in decreased expression of NFKBIA protein Sulindac results in decreased phosphorylation of NFKBIA protein [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of NFKBIA mRNA
CTD
PMID:11591705 PMID:15489888 PMID:18059344 PMID:18575716 PMID:20371263
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfu1
NFU1 iron-sulfur cluster scaffold
decreases expression
EXP
Sulindac results in decreased expression of NFU1 mRNA
CTD
PMID:24136188
NCBI chr 4:121,016,316...121,036,925
Ensembl chr 4:119,459,061...119,480,373
G
Npc1
NPC intracellular cholesterol transporter 1
increases expression
ISO
Sulindac results in increased expression of NPC1 mRNA
CTD
PMID:11906190
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
G
Nphp1
nephrocystin 1
increases expression
EXP
Sulindac results in increased expression of NPHP1 mRNA
CTD
PMID:24136188
NCBI chr 3:135,413,927...135,469,505
Ensembl chr 3:114,960,650...115,016,234
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases activity increases expression
ISO
Sulindac results in increased activity of NQO1 protein Sulindac results in increased expression of NQO1 mRNA
CTD
PMID:11093808 PMID:17985343
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
decreases expression
EXP
Sulindac results in decreased expression of NSMF mRNA
CTD
PMID:24136188
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
G
Nudt16l1
nudix hydrolase 16 like 1
increases expression
EXP
Sulindac results in increased expression of NUDT16L1 mRNA
CTD
PMID:24136188
NCBI chr10:10,636,174...10,638,090
Ensembl chr10:10,636,174...10,688,370
G
Numb
NUMB, endocytic adaptor protein
increases expression
EXP
Sulindac results in increased expression of NUMB mRNA
CTD
PMID:24136188
NCBI chr 6:109,162,499...109,284,527
Ensembl chr 6:103,431,400...103,553,354
G
Nup37
nucleoporin 37
increases expression
EXP
Sulindac results in increased expression of NUP37 mRNA
CTD
PMID:24136188
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
G
Nupr2
nuclear protein 2, transcriptional regulator
increases expression
EXP
Sulindac results in increased expression of NUPR2 mRNA
CTD
PMID:24136188
NCBI chr12:32,436,233...32,439,391
Ensembl chr12:26,799,800...26,803,304
G
Orc4
origin recognition complex, subunit 4
decreases expression
ISO
Sulindac results in decreased expression of ORC4 mRNA
CTD
PMID:11906190
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
G
Osbpl9
oxysterol binding protein-like 9
decreases expression
EXP
Sulindac results in decreased expression of OSBPL9 mRNA
CTD
PMID:24136188
NCBI chr 5:123,819,106...123,962,213
Ensembl chr 5:123,819,104...123,962,196
G
Ostf1
osteoclast stimulating factor 1
increases expression
ISO
Sulindac results in increased expression of OSTF1 mRNA
CTD
PMID:11906190
NCBI chr 1:216,002,037...216,049,226
Ensembl chr 1:216,002,044...216,049,221
G
Ostm1
osteoclastogenesis associated transmembrane protein 1
increases expression
EXP
Sulindac results in increased expression of OSTM1 mRNA
CTD
PMID:24136188
NCBI chr20:46,071,657...46,187,049
Ensembl chr20:46,153,075...46,187,023
G
Otud1
OTU deubiquitinase 1
increases expression
ISO
Sulindac results in increased expression of OTUD1 mRNA
CTD
PMID:11906190
NCBI chr17:87,168,248...87,171,098
Ensembl chr17:82,259,840...82,262,995
G
P4hb
prolyl 4-hydroxylase subunit beta
decreases expression
ISO
Sulindac results in decreased expression of P4HB mRNA
CTD
PMID:32535746
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pacsin3
protein kinase C and casein kinase substrate in neurons 3
increases expression
EXP
Sulindac results in increased expression of PACSIN3 mRNA
CTD
PMID:24136188
NCBI chr 3:77,227,187...77,235,820
Ensembl chr 3:77,222,710...77,235,811
G
Pak6
p21 (RAC1) activated kinase 6
decreases expression
EXP
Sulindac results in decreased expression of PAK6 mRNA
CTD
PMID:24136188
NCBI chr 3:126,092,576...126,128,320
Ensembl chr 3:105,638,653...105,672,975
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases activity
ISO
[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased cleavage of PARP1 protein]; Sulindac promotes the reaction [Deferoxamine results in increased cleavage of PARP1 protein] Sulindac results in increased activity of PARP1 protein
CTD
PMID:15713900 PMID:18281123 PMID:21882223
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Parp14
poly (ADP-ribose) polymerase family, member 14
decreases expression
EXP
Sulindac results in decreased expression of PARP14 mRNA
CTD
PMID:24136188
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
G
Pbrm1
polybromo 1
decreases expression
EXP
Sulindac results in decreased expression of PBRM1 mRNA
CTD
PMID:24136188
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
G
Pcbp1
poly(rC) binding protein 1
increases expression
EXP
Sulindac results in increased expression of PCBP1 mRNA
CTD
PMID:24136188
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
G
Pcdh17
protocadherin 17
decreases expression
ISO
Sulindac results in decreased expression of PCDH17 mRNA
CTD
PMID:11906190
NCBI chr15:60,222,088...60,316,172
Ensembl chr15:60,222,004...60,313,999
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
increases expression
ISO
Sulindac results in increased expression of PCK2 mRNA
CTD
PMID:11906190
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pcna
proliferating cell nuclear antigen
decreases expression multiple interactions
ISO EXP
Sulindac results in decreased expression of PCNA protein epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]]; kaempferol promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein]
CTD
PMID:15020200 PMID:29999212
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pdgfa
platelet derived growth factor subunit A
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PDGFA mRNA
CTD
PMID:20371263
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
Sulindac results in increased expression of PDLIM7 mRNA
CTD
PMID:11906190
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
G
Per1
period circadian regulator 1
decreases expression
EXP
Sulindac results in decreased expression of PER1 mRNA
CTD
PMID:24136188
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Pex2
peroxisomal biogenesis factor 2
increases expression
EXP
Sulindac results in increased expression of PEX2 mRNA
CTD
PMID:24136188
NCBI chr 2:96,050,380...96,072,928
Ensembl chr 2:96,045,958...96,073,404
G
Pfdn6
prefoldin subunit 6
increases expression
EXP
Sulindac results in increased expression of PFDN6 mRNA
CTD
PMID:24136188
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
G
Pgap2
post-GPI attachment to proteins 2
decreases expression
EXP
Sulindac results in decreased expression of PGAP2 mRNA
CTD
PMID:24136188
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
G
Pi4k2b
phosphatidylinositol 4-kinase type 2 beta
increases expression
EXP
Sulindac results in increased expression of PI4K2B mRNA
CTD
PMID:24136188
NCBI chr14:58,221,790...58,248,716
Ensembl chr14:58,220,437...58,248,673
G
Pi4ka
phosphatidylinositol 4-kinase alpha
increases expression
EXP
Sulindac results in increased expression of PI4KA mRNA
CTD
PMID:24136188
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
G
Pigc
phosphatidylinositol glycan anchor biosynthesis, class C
increases expression
EXP
Sulindac results in increased expression of PIGC mRNA
CTD
PMID:24136188
NCBI chr13:74,343,619...74,346,148
Ensembl chr13:74,296,854...74,346,211
G
Pigy
phosphatidylinositol glycan anchor biosynthesis, class Y
increases expression
EXP
Sulindac results in increased expression of PIGY mRNA
CTD
PMID:24136188
NCBI chr 8:20,689,621...20,691,863
Ensembl chr 8:20,689,502...20,692,585
G
Pisd
phosphatidylserine decarboxylase
decreases expression
EXP
Sulindac results in decreased expression of PISD mRNA
CTD
PMID:24136188
NCBI chr14:77,941,927...77,991,021
Ensembl chr14:77,941,948...77,991,003
G
Pithd1
PITH domain containing 1
increases expression
EXP
Sulindac results in increased expression of PITHD1 mRNA
CTD
PMID:24136188
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:148,205,998...148,217,080
G
Pkd1
polycystin 1, transient receptor potential channel interacting
increases expression
ISO
Sulindac results in increased expression of PKD1 mRNA
CTD
PMID:11906190
NCBI chr10:13,573,779...13,621,138
Ensembl chr10:13,573,021...13,621,128
G
Pla2g4a
phospholipase A2 group 4A
multiple interactions decreases expression
ISO
Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein] Sulindac results in decreased expression of PLA2G4A mRNA
CTD
PMID:10706128 PMID:15816863
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Plat
plasminogen activator, tissue type
multiple interactions
ISO
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of PLAT mRNA
CTD
PMID:12628509
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plcg1
phospholipase C, gamma 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PLCG1 mRNA
CTD
PMID:20371263
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330
G
Plec
plectin
increases expression
EXP
Sulindac results in increased expression of PLEC mRNA
CTD
PMID:24136188
NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:107,887,764...107,945,467
G
Plekhb2
pleckstrin homology domain containing B2
decreases expression
EXP
Sulindac results in decreased expression of PLEKHB2 mRNA
CTD
PMID:24136188
NCBI chr 9:37,049,580...37,082,231
Ensembl chr 9:37,038,751...37,082,231
G
Plekhf1
pleckstrin homology and FYVE domain containing 1
increases expression
ISO
Sulindac results in increased expression of PLEKHF1 mRNA
CTD
PMID:11906190
NCBI chr 1:90,908,304...90,915,862
Ensembl chr 1:90,904,742...90,915,820
G
Plxna3
plexin A3
increases expression
ISO
Sulindac results in increased expression of PLXNA3 mRNA
CTD
PMID:11906190
NCBI chr X:152,115,699...152,131,608
Ensembl chr X:152,115,819...152,131,603
G
Pml
PML nuclear body scaffold
increases expression
ISO
Sulindac results in increased expression of PML mRNA
CTD
PMID:16273229
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pole4
DNA polymerase epsilon 4, accessory subunit
decreases expression
EXP
Sulindac results in decreased expression of POLE4 mRNA
CTD
PMID:24136188
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097
G
Polr2c
RNA polymerase II subunit C
decreases expression
EXP
Sulindac results in decreased expression of POLR2C mRNA
CTD
PMID:24136188
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
G
Pomp
proteasome maturation protein
decreases expression
EXP
Sulindac results in decreased expression of POMP mRNA
CTD
PMID:24136188
NCBI chr12:7,162,098...7,174,737
Ensembl chr12:7,160,714...7,174,715
G
Pon3
paraoxonase 3
decreases expression
EXP
Sulindac results in decreased expression of PON3 mRNA
CTD
PMID:24136188
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression affects response to substance
ISO
Sulindac results in increased expression of PPARD protein PPARD protein affects the susceptibility to Sulindac
CTD
PMID:10866668 PMID:21400612
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
EXP
Sulindac results in increased expression of PPP2CB mRNA
CTD
PMID:24136188
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:58,558,122...58,579,576
G
Ppp6r1
protein phosphatase 6, regulatory subunit 1
decreases expression
EXP
Sulindac results in decreased expression of PPP6R1 mRNA
CTD
PMID:24136188
NCBI chr 1:69,190,856...69,217,598
Ensembl chr 1:69,189,822...69,216,272
G
Ppt1
palmitoyl-protein thioesterase 1
decreases expression
EXP
Sulindac results in decreased expression of PPT1 mRNA
CTD
PMID:24136188
NCBI chr 5:140,406,318...140,427,201
Ensembl chr 5:135,121,163...135,142,048
G
Prdm15
PR/SET domain 15
increases expression
EXP
Sulindac results in increased expression of PRDM15 mRNA
CTD
PMID:24136188
NCBI chr11:37,164,608...37,225,172
Ensembl chr11:37,165,575...37,222,207
G
Prdx1
peroxiredoxin 1
increases expression
EXP
Sulindac results in increased expression of PRDX1 mRNA
CTD
PMID:24136188
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:130,147,204...130,162,856
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKAA2 mRNA
CTD
PMID:20371263
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACA mRNA
CTD
PMID:20371263
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430
G
Prkacb
protein kinase cAMP-activated catalytic subunit beta
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of PRKACB mRNA
CTD
PMID:20371263
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:235,636,885...235,726,198
G
Prkci
protein kinase C, iota
increases expression
EXP
Sulindac results in increased expression of PRKCI mRNA
CTD
PMID:24136188
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:112,321,929...112,382,352
G
Prodh
proline dehydrogenase
decreases expression
EXP
Sulindac results in decreased expression of PRODH mRNA
CTD
PMID:24136188
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prorp
protein only RNase P catalytic subunit
increases expression
EXP
Sulindac results in increased expression of PRORP mRNA
CTD
PMID:24136188
NCBI chr 6:72,669,659...72,762,419
Ensembl chr 6:72,670,847...72,762,416
G
Psma5
proteasome 20S subunit alpha 5
decreases expression
EXP
Sulindac results in decreased expression of PSMA5 mRNA
CTD
PMID:24136188
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
G
Psmb5
proteasome 20S subunit beta 5
increases expression
EXP
Sulindac results in increased expression of PSMB5 mRNA
CTD
PMID:24136188
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
G
Psmc2
proteasome 26S subunit, ATPase 2
increases expression
EXP
Sulindac results in increased expression of PSMC2 mRNA
CTD
PMID:24136188
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
G
Psmc5
proteasome 26S subunit, ATPase 5
decreases expression
EXP
Sulindac results in decreased expression of PSMC5 mRNA
CTD
PMID:24136188
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
G
Psmc6
proteasome 26S subunit, ATPase 6
increases expression
EXP
Sulindac results in increased expression of PSMC6 mRNA
CTD
PMID:24136188
NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression increases expression
EXP
Sulindac results in decreased expression of PTGS1 mRNA alternative form Sulindac results in increased expression of PTGS1 mRNA
CTD
PMID:11375891 PMID:12586211
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions decreases expression increases expression decreases activity
ISO EXP
[Sulindac co-treated with Deferoxamine] results in increased expression of PTGS2 protein; Sulindac inhibits the reaction [Mitomycin results in increased expression of PTGS2 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; Sulindac promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein] Sulindac results in decreased expression of PTGS2 protein Sulindac results in increased expression of PTGS2 mRNA [Olive Oil co-treated with Sulindac] results in decreased expression of PTGS2 protein; epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein]]; Sulindac inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein] Sulindac results in decreased activity of PTGS2 protein Sulindac results in decreased expression of PTGS2 mRNA
CTD
PMID:10706128 PMID:11375891 PMID:11504793 PMID:11910360 PMID:12586211 PMID:15309441 PMID:15489888 PMID:15793875 PMID:21882223 PMID:29999212 More...
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptp4a2
protein tyrosine phosphatase 4A2
increases expression
EXP
Sulindac results in increased expression of PTP4A2 mRNA
CTD
PMID:24136188
NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899
G
Ptprn
protein tyrosine phosphatase, receptor type, N
decreases expression
EXP
Sulindac results in decreased expression of PTPRN mRNA
CTD
PMID:24136188
NCBI chr 9:76,741,010...76,756,704
Ensembl chr 9:76,741,016...76,756,190
G
Pus10
pseudouridine synthase 10
increases expression
EXP
Sulindac results in increased expression of PUS10 mRNA
CTD
PMID:24136188
NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046
G
Qtrt1
queuine tRNA-ribosyltransferase catalytic subunit 1
decreases expression
EXP
Sulindac results in decreased expression of QTRT1 mRNA
CTD
PMID:24136188
NCBI chr 8:19,965,801...19,973,843
Ensembl chr 8:19,966,336...19,973,837
G
Rab28
RAB28, member RAS oncogene family
increases expression
EXP
Sulindac results in increased expression of RAB28 mRNA
CTD
PMID:24136188
NCBI chr14:69,245,846...69,322,968
Ensembl chr14:69,245,854...69,322,967
G
Rab2b
RAB2B, member RAS oncogene family
increases expression
EXP
Sulindac results in increased expression of RAB2B mRNA
CTD
PMID:24136188
NCBI chr15:24,968,364...24,988,990
Ensembl chr15:24,968,803...24,989,113
G
Rac2
Rac family small GTPase 2
decreases expression
EXP
Sulindac results in decreased expression of RAC2 mRNA
CTD
PMID:24136188
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:110,116,260...110,128,720
G
Ramac
RNA guanine-7 methyltransferase activating subunit
decreases expression
EXP
Sulindac results in decreased expression of RAMAC mRNA
CTD
PMID:24136188
NCBI chr 1:135,708,529...135,714,417
Ensembl chr 1:135,708,535...135,722,151
G
Rasa1
RAS p21 protein activator 1
decreases expression
EXP
Sulindac results in decreased expression of RASA1 mRNA
CTD
PMID:24136188
NCBI chr 2:17,593,136...17,676,707
Ensembl chr 2:15,857,980...15,940,854
G
Rassf6
Ras association domain family member 6
increases expression
EXP
Sulindac results in increased expression of RASSF6 mRNA
CTD
PMID:24136188
NCBI chr14:17,433,328...17,473,565
Ensembl chr14:17,442,789...17,473,330
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
Sulindac results in decreased expression of RB1 protein
CTD
PMID:16488075
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rbbp7
RB binding protein 7, chromatin remodeling factor
increases expression
EXP
Sulindac results in increased expression of RBBP7 mRNA
CTD
PMID:24136188
NCBI chr X:35,544,873...35,563,030
Ensembl chr X:31,913,081...31,931,226
G
Rbm42
RNA binding motif protein 42
decreases expression
EXP
Sulindac results in decreased expression of RBM42 mRNA
CTD
PMID:24136188
NCBI chr 1:85,898,618...85,908,569
Ensembl chr 1:85,898,625...85,908,573
G
Rbm45
RNA binding motif protein 45
increases expression
EXP
Sulindac results in increased expression of RBM45 mRNA
CTD
PMID:24136188
NCBI chr 3:81,713,214...81,728,190
Ensembl chr 3:61,305,924...61,320,952
G
Rbm47
RNA binding motif protein 47
decreases expression
EXP
Sulindac results in decreased expression of RBM47 mRNA
CTD
PMID:24136188
NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431
G
Rbx1
ring-box 1
increases expression
EXP
Sulindac results in increased expression of RBX1 mRNA
CTD
PMID:24136188
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:112,990,835...113,001,051
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions increases expression increases activity
ISO
Sulindac affects the localization of RELA protein [[Sulindac co-treated with Arsenic Trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; Sulindac inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of RELA protein] Sulindac results in increased expression of RELA mRNA Sulindac results in increased activity of RELA protein
CTD
PMID:10328874 PMID:15489888 PMID:16159934 PMID:16273229 PMID:18059344 PMID:18575716 More...
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
multiple interactions decreases activity
ISO
Sulindac inhibits the reaction [Furosemide results in increased expression of REN protein] Sulindac results in decreased activity of REN protein
CTD
PMID:2203262 PMID:3884224 PMID:4028619
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Ret
ret proto-oncogene
affects expression
ISO
Sulindac affects the expression of RET protein
CTD
PMID:12388792
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
RGD1311745
similar to RIKEN cDNA 1110059G10
increases expression
EXP
Sulindac results in increased expression of RGD1311745 mRNA
CTD
PMID:24136188
NCBI chr 8:122,598,363...122,609,127
Ensembl chr 8:122,598,401...122,609,168
G
Rgp1
RGP1 homolog, RAB6A GEF complex partner 1
increases expression
EXP
Sulindac results in increased expression of RGP1 mRNA
CTD
PMID:24136188
NCBI chr 5:62,630,253...62,638,872
Ensembl chr 5:57,834,629...57,843,086
G
Rmdn3
regulator of microtubule dynamics 3
decreases expression
EXP
Sulindac results in decreased expression of RMDN3 mRNA
CTD
PMID:24136188
NCBI chr 3:126,579,811...126,601,016
Ensembl chr 3:106,125,951...106,146,586
G
Rnase1
ribonuclease A family member 1, pancreatic
decreases expression
ISO
Sulindac results in decreased expression of RNASE1 mRNA
CTD
PMID:11906190
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
G
Rnf220
ring finger protein 220
increases expression
EXP
Sulindac results in increased expression of RNF220 mRNA
CTD
PMID:24136188
NCBI chr 5:130,739,173...130,961,386
Ensembl chr 5:130,739,183...130,961,418
G
Rnf26
ring finger protein 26
decreases expression
ISO
Sulindac results in decreased expression of RNF26 mRNA
CTD
PMID:11906190
NCBI chr 8:44,454,551...44,456,745
Ensembl chr 8:44,454,292...44,457,331
G
Rnpepl1
arginyl aminopeptidase like 1
decreases expression
EXP
Sulindac results in decreased expression of RNPEPL1 mRNA
CTD
PMID:24136188
NCBI chr 9:93,476,600...93,486,331
Ensembl chr 9:93,472,390...93,486,331
G
Rpia
ribose 5-phosphate isomerase A
decreases expression
EXP
Sulindac results in decreased expression of RPIA mRNA
CTD
PMID:24136188
NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355
G
Rragc
Ras-related GTP binding C
decreases expression
EXP
Sulindac results in decreased expression of RRAGC mRNA
CTD
PMID:24136188
NCBI chr 5:136,148,239...136,167,773
Ensembl chr 5:136,148,276...136,167,767
G
Rxra
retinoid X receptor alpha
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of RXRA mRNA
CTD
PMID:20371263
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Sae1
SUMO1 activating enzyme subunit 1
decreases expression
EXP
Sulindac results in decreased expression of SAE1 mRNA
CTD
PMID:24136188
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
G
Sap30l
SAP30-like
decreases expression
EXP
Sulindac results in decreased expression of SAP30L mRNA
CTD
PMID:24136188
NCBI chr10:41,979,730...41,992,307
Ensembl chr10:41,979,687...41,987,658
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
Sulindac results in increased expression of SAT1 mRNA
CTD
PMID:14506281 PMID:16262603
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Sat2
spermidine/spermine N1-acetyltransferase family member 2
increases activity increases expression
ISO
Sulindac results in increased activity of SAT2 protein Sulindac results in increased expression of SAT2 mRNA
CTD
PMID:17474863
NCBI chr10:54,340,756...54,343,507
Ensembl chr10:54,340,372...54,343,224
G
Scamp1
secretory carrier membrane protein 1
increases expression
EXP
Sulindac results in increased expression of SCAMP1 mRNA
CTD
PMID:24136188
NCBI chr 2:25,433,958...25,516,734
Ensembl chr 2:25,433,959...25,516,673
G
Sco1
synthesis of cytochrome C oxidase 1
increases expression
EXP
Sulindac results in increased expression of SCO1 mRNA
CTD
PMID:24136188
NCBI chr10:51,744,656...51,757,246
Ensembl chr10:51,744,656...51,757,237
G
Sdhaf3
succinate dehydrogenase complex assembly factor 3
increases expression
EXP
Sulindac results in increased expression of SDHAF3 mRNA
CTD
PMID:24136188
NCBI chr 4:35,100,533...35,160,740
Ensembl chr 4:35,100,506...35,160,749
G
Sec62
SEC62 homolog, preprotein translocation factor
decreases expression
EXP
Sulindac results in decreased expression of SEC62 mRNA
CTD
PMID:24136188
NCBI chr 2:112,570,810...112,598,198
Ensembl chr 2:112,570,819...112,601,814
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
EXP
Sulindac results in decreased expression of SEC63 mRNA
CTD
PMID:24136188
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
G
Septin10
septin 10
decreases expression
EXP
Sulindac results in decreased expression of SEPTIN10 mRNA
CTD
PMID:24136188
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
G
Serpinb1a
serpin family B member 1A
increases expression
ISO
Sulindac results in increased expression of SERPINB1 mRNA
CTD
PMID:11507085
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Set
Set nuclear proto-oncogene
decreases expression
EXP
Sulindac results in decreased expression of SET mRNA
CTD
PMID:24136188
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
G
Sft2d2
SFT2 domain containing 2
increases expression
EXP
Sulindac results in increased expression of SFT2D2 mRNA
CTD
PMID:24136188
NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112
G
Shc1
SHC adaptor protein 1
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SHC1 mRNA]
CTD
PMID:15190207
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:174,837,930...174,849,536
G
Shmt2
serine hydroxymethyltransferase 2
increases expression
EXP
Sulindac results in increased expression of SHMT2 mRNA
CTD
PMID:24136188
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:63,358,961...63,364,236
G
Sirt1
sirtuin 1
increases expression
ISO
Sulindac results in increased expression of SIRT1 mRNA
CTD
PMID:11906190
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Skic8
SKI8 subunit of superkiller complex
decreases expression
EXP
Sulindac results in decreased expression of SKIC8 mRNA
CTD
PMID:24136188
NCBI chr 8:63,999,669...64,016,959
Ensembl chr 8:55,103,545...55,120,813
G
Slc16a6
solute carrier family 16, member 6
increases expression
ISO
Sulindac results in increased expression of SLC16A6 mRNA
CTD
PMID:11906190
NCBI chr10:94,923,888...94,946,990
Ensembl chr10:94,426,244...94,448,779
G
Slc18b1
solute carrier family 18 member B1
increases expression
EXP
Sulindac results in increased expression of SLC18B1 mRNA
CTD
PMID:24136188
NCBI chr 1:21,628,235...21,670,807
Ensembl chr 1:21,628,237...21,670,684
G
Slc22a1
solute carrier family 22 member 1
decreases activity
ISO
Sulindac results in decreased activity of SLC22A1 protein
CTD
PMID:12388633
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
decreases activity
ISO
Sulindac results in decreased activity of SLC22A2 protein
CTD
PMID:12388633
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a25
solute carrier family 22, member 25
decreases activity
ISO
Sulindac results in decreased activity of SLC22A9 protein
CTD
PMID:12388633
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
G
Slc22a6
solute carrier family 22 member 6
decreases activity
ISO
Sulindac results in decreased activity of SLC22A6 protein
CTD
PMID:12388633
NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a7
solute carrier family 22 member 7
decreases activity
ISO
Sulindac results in decreased activity of SLC22A7 protein
CTD
PMID:12388633
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:14,547,849...14,553,921
G
Slc27a4
solute carrier family 27 member 4
decreases expression
EXP
Sulindac results in decreased expression of SLC27A4 mRNA
CTD
PMID:24136188
NCBI chr 3:13,075,022...13,087,943
Ensembl chr 3:13,075,022...13,087,943
G
Slc30a1
solute carrier family 30 member 1
increases expression
ISO
Sulindac results in increased expression of SLC30A1 mRNA
CTD
PMID:11906190
NCBI chr13:106,022,019...106,025,892
Ensembl chr13:103,491,037...103,494,910
G
Slc30a5
solute carrier family 30 member 5
decreases expression
EXP
Sulindac results in decreased expression of SLC30A5 mRNA
CTD
PMID:24136188
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
G
Slc38a2
solute carrier family 38, member 2
increases expression
ISO
Sulindac results in increased expression of SLC38A2 mRNA
CTD
PMID:11906190
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:127,851,267...127,863,436
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
Sulindac results in increased expression of SLC3A2 mRNA
CTD
PMID:11906190
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Slc4a1ap
solute carrier family 4 member 1 adaptor protein
decreases expression
EXP
Sulindac results in decreased expression of SLC4A1AP mRNA
CTD
PMID:24136188
NCBI chr 6:24,905,941...24,933,651
Ensembl chr 6:24,905,941...24,933,815
G
Slc7a1
solute carrier family 7 member 1
increases expression
ISO
Sulindac results in increased expression of SLC7A1 mRNA
CTD
PMID:11906190
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SLCO1A2 mRNA
CTD
PMID:20371263
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slfn3
schlafen 3
decreases expression
EXP
Sulindac results in decreased expression of SLFN3 mRNA
CTD
PMID:24136188
NCBI chr10:68,020,482...68,060,248
Ensembl chr10:68,055,355...68,060,603
G
Smc1a
structural maintenance of chromosomes 1A
decreases expression
EXP
Sulindac results in decreased expression of SMC1A mRNA
CTD
PMID:24136188
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
G
Smu1
SMU1, DNA replication regulator and spliceosomal factor
decreases expression
EXP
Sulindac results in decreased expression of SMU1 mRNA
CTD
PMID:24136188
NCBI chr 5:60,652,680...60,671,251
Ensembl chr 5:55,856,246...55,875,300
G
Snrnp27
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
increases expression
EXP
Sulindac results in increased expression of SNRNP27 mRNA
CTD
PMID:24136188
NCBI chr 4:119,123,676...119,133,234
Ensembl chr 4:119,121,877...119,133,234
G
Snx21
sorting nexin family member 21
increases expression
ISO
Sulindac results in increased expression of SNX21 mRNA
CTD
PMID:11906190
NCBI chr 3:153,522,474...153,532,235
Ensembl chr 3:153,522,486...153,532,221
G
Snx25
sorting nexin 25
increases expression
ISO
Sulindac results in increased expression of SNX25 mRNA
CTD
PMID:11906190
NCBI chr16:46,134,552...46,238,471
Ensembl chr16:46,125,804...46,238,440
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
Sulindac inhibits the reaction [PLA2G4A gene mutant form results in decreased expression of SOD1 protein]
CTD
PMID:15816863
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA]
CTD
PMID:15190207
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spred3
sprouty-related, EVH1 domain containing 3
decreases expression
EXP
Sulindac results in decreased expression of SPRED3 mRNA
CTD
PMID:24136188
NCBI chr 1:93,586,259...93,597,692
Ensembl chr 1:84,459,314...84,470,249
G
Sqstm1
sequestosome 1
increases expression
ISO
Sulindac results in increased expression of SQSTM1 mRNA
CTD
PMID:11906190
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
EXP ISO
[[Azoxymethane co-treated with Sulindac] results in increased expression of CSK protein] which results in increased phosphorylation of and results in decreased activity of SRC protein Sulindac results in increased phosphorylation of and results in decreased activity of SRC protein
CTD
PMID:18644992
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Sulindac results in increased expression of SRXN1 protein
CTD
PMID:27358234
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Ss18
SS18 subunit of BAF chromatin remodeling complex
decreases expression
EXP
Sulindac results in decreased expression of SS18 mRNA
CTD
PMID:24136188
NCBI chr18:5,773,042...5,835,696
Ensembl chr18:5,773,042...5,835,333
G
Ssu72
SSU72 homolog, RNA polymerase II CTD phosphatase
decreases expression
EXP
Sulindac results in decreased expression of SSU72 mRNA
CTD
PMID:24136188
NCBI chr 5:166,312,267...166,343,432
Ensembl chr 5:166,313,650...166,343,429
G
Stac3
SH3 and cysteine rich domain 3
decreases expression
EXP
Sulindac results in decreased expression of STAC3 mRNA
CTD
PMID:24136188
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
G
Stard3
StAR-related lipid transfer domain containing 3
increases expression
EXP
Sulindac results in increased expression of STARD3 mRNA
CTD
PMID:24136188
NCBI chr10:83,357,329...83,379,873
Ensembl chr10:83,357,359...83,550,976
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation decreases expression
ISO
BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein modified form]; BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein] Sulindac results in decreased phosphorylation of STAT3 protein Sulindac results in decreased expression of STAT3 protein; Sulindac results in decreased expression of STAT3 protein modified form
CTD
PMID:11861373 PMID:17401459
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stc2
stanniocalcin 2
increases expression
ISO
Sulindac results in increased expression of STC2 mRNA
CTD
PMID:11906190
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Stoml2
stomatin like 2
increases expression
EXP
Sulindac results in increased expression of STOML2 mRNA
CTD
PMID:24136188
NCBI chr 5:62,052,042...62,055,639
Ensembl chr 5:57,256,220...57,259,920
G
Strbp
spermatid perinuclear RNA binding protein
increases expression
EXP
Sulindac results in increased expression of STRBP mRNA
CTD
PMID:24136188
NCBI chr 3:21,328,310...21,467,753
Ensembl chr 3:21,337,855...21,414,949
G
Stx7
syntaxin 7
decreases expression
EXP
Sulindac results in decreased expression of STX7 mRNA
CTD
PMID:24136188
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Stxbp2
syntaxin binding protein 2
increases expression
ISO
Sulindac results in increased expression of STXBP2 mRNA
CTD
PMID:11906190
NCBI chr12:1,689,364...1,701,145
Ensembl chr12:1,689,410...1,700,458
G
Suclg1
succinate-CoA ligase GDP/ADP-forming subunit alpha
increases expression
EXP
Sulindac results in increased expression of SUCLG1 mRNA
CTD
PMID:24136188
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
G
Sult1b1
sulfotransferase family 1B member 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1B1 mRNA
CTD
PMID:20371263
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
G
Sult1e1
sulfotransferase family 1E member 1
multiple interactions decreases activity
EXP ISO
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT1E1 mRNA Sulindac results in decreased activity of SULT1E1 protein
CTD
PMID:17073578 PMID:20371263
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,422,324...20,439,275
G
Sult2a6
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of SULT2A6 mRNA
CTD
PMID:20371263
NCBI chr 1:74,911,097...74,962,239
Ensembl chr 1:74,911,100...75,508,134
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
ISO
Sulindac results in decreased expression of SUMO3 mRNA
CTD
PMID:11906190
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
G
Sun2
Sad1 and UNC84 domain containing 2
decreases expression
ISO
Sulindac results in decreased expression of SUN2 mRNA
CTD
PMID:11906190
NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:111,275,380...111,292,553
G
Supt7l
SPT7 like, STAGA complex subunit gamma
decreases expression
EXP
Sulindac results in decreased expression of SUPT7L mRNA
CTD
PMID:24136188
NCBI chr 6:24,933,941...24,944,656
Ensembl chr 6:24,933,923...24,944,654
G
Syp
synaptophysin
decreases expression
EXP
Sulindac results in decreased expression of SYP mRNA
CTD
PMID:24136188
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Syt15
synaptotagmin 15
decreases expression
EXP
Sulindac results in decreased expression of SYT15 mRNA
CTD
PMID:24136188
NCBI chr16:9,532,478...9,543,288
Ensembl chr16:9,532,478...9,543,281
G
Tbc1d10b
TBC1 domain family, member 10b
increases expression
ISO
Sulindac results in increased expression of TBC1D10B mRNA
CTD
PMID:11906190
NCBI chr 1:181,814,972...181,826,628
Ensembl chr 1:181,814,972...181,826,628
G
Tbk1
TANK-binding kinase 1
increases expression
ISO
Sulindac results in increased expression of TBK1 mRNA
CTD
PMID:11093808
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
G
Tbx3
T-box transcription factor 3
increases expression
ISO
Sulindac results in increased expression of TBX3 mRNA
CTD
PMID:11906190
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
G
Tceanc2
transcription elongation factor A N-terminal and central domain containing 2
increases expression
EXP
Sulindac results in increased expression of TCEANC2 mRNA
CTD
PMID:24136188
NCBI chr 5:121,923,959...121,963,018
Ensembl chr 5:121,923,956...121,962,183
G
Tcf4
transcription factor 4
decreases activity multiple interactions
ISO
Sulindac results in decreased activity of TCF4 protein TCF4 protein promotes the reaction [Sulindac results in increased susceptibility to TNFSF10 protein]
CTD
PMID:11593435 PMID:21171083
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tdo2
tryptophan 2,3-dioxygenase
decreases activity multiple interactions
EXP
Sulindac results in decreased activity of TDO2 protein [Sulindac results in decreased activity of TDO2 protein] which results in decreased abundance of Dopamine; [Sulindac results in decreased activity of TDO2 protein] which results in increased abundance of Serotonin
CTD
PMID:16952380
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
G
Tek
TEK receptor tyrosine kinase
multiple interactions
ISO
Sulindac analog results in decreased phosphorylation of and results in decreased activity of TEK protein
CTD
PMID:16215210
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:109,607,077...109,733,804
G
Tfdp1
transcription factor Dp-1
decreases expression
EXP
Sulindac results in decreased expression of TFDP1 mRNA
CTD
PMID:24136188
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:76,162,043...76,200,817
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Sulindac results in increased expression of TGFB1 protein
CTD
PMID:11496082
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgm2
transglutaminase 2
multiple interactions
ISO
Sulindac inhibits the reaction [CDKN1A protein results in increased expression of TGM2 mRNA]
CTD
PMID:15190207
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Thap7
THAP domain containing 7
increases expression
EXP
Sulindac results in increased expression of THAP7 mRNA
CTD
PMID:24136188
NCBI chr11:83,482,958...83,486,136
Ensembl chr11:83,483,037...83,486,436
G
Thrsp
thyroid hormone responsive
decreases expression
EXP
Sulindac results in decreased expression of THRSP mRNA
CTD
PMID:24136188
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Timm10
translocase of inner mitochondrial membrane 10
increases expression
EXP
Sulindac results in increased expression of TIMM10 mRNA
CTD
PMID:24136188
NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940
G
Timmdc1
translocase of inner mitochondrial membrane domain containing 1
increases expression
EXP
Sulindac results in increased expression of TIMMDC1 mRNA
CTD
PMID:24136188
NCBI chr11:62,228,990...62,259,389
Ensembl chr11:62,229,058...62,254,699
G
Timp1
TIMP metallopeptidase inhibitor 1
affects expression
ISO
Sulindac affects the expression of TIMP1 protein
CTD
PMID:12388792
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Timp3
TIMP metallopeptidase inhibitor 3
multiple interactions
ISO
[Sulindac co-treated with epigallocatechin gallate] results in decreased expression of TIMP3 mRNA
CTD
PMID:12628509
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
G
Tjp2
tight junction protein 2
increases expression
EXP
Sulindac results in increased expression of TJP2 mRNA
CTD
PMID:24136188
NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:221,709,745...221,838,295
G
Tlr2
toll-like receptor 2
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of TLR2 mRNA
CTD
PMID:20371263
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tm2d1
TM2 domain containing 1
increases expression
EXP
Sulindac results in increased expression of TM2D1 mRNA
CTD
PMID:24136188
NCBI chr 5:113,020,793...113,062,134
Ensembl chr 5:113,020,760...113,050,933
G
Tm7sf3
transmembrane 7 superfamily member 3
decreases expression
ISO
Sulindac results in decreased expression of TM7SF3 mRNA
CTD
PMID:11093808
NCBI chr 4:179,518,127...179,550,154
Ensembl chr 4:179,518,130...179,550,154
G
Tmed9
transmembrane p24 trafficking protein 9
decreases expression
ISO
Sulindac results in decreased expression of TMED9 mRNA
CTD
PMID:11906190
NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,029,646...9,034,176
G
Tmem127
transmembrane protein 127
increases expression
ISO
Sulindac results in increased expression of TMEM127 mRNA
CTD
PMID:11906190
NCBI chr 3:114,466,095...114,478,894
Ensembl chr 3:114,466,171...114,477,519
G
Tmem141
transmembrane protein 141
increases expression
EXP
Sulindac results in increased expression of TMEM141 mRNA
CTD
PMID:24136188
NCBI chr 3:8,439,533...8,441,491
Ensembl chr 3:8,439,533...8,441,491
G
Tmem209
transmembrane protein 209
decreases expression
EXP
Sulindac results in decreased expression of TMEM209 mRNA
CTD
PMID:24136188
NCBI chr 4:59,102,943...59,128,636
Ensembl chr 4:59,101,550...59,128,630
G
Tmem39a
transmembrane protein 39a
increases expression
ISO
Sulindac results in increased expression of TMEM39A mRNA
CTD
PMID:11906190
NCBI chr11:62,160,631...62,189,964
Ensembl chr11:62,160,631...62,189,964
G
Tmem60
transmembrane protein 60
increases expression
EXP
Sulindac results in increased expression of TMEM60 mRNA
CTD
PMID:24136188
NCBI chr 4:14,210,029...14,214,884
Ensembl chr 4:14,210,029...14,215,063
G
Tmx1
thioredoxin-related transmembrane protein 1
increases expression
EXP
Sulindac results in increased expression of TMX1 mRNA
CTD
PMID:24136188
NCBI chr 6:88,960,691...88,971,744
Ensembl chr 6:88,960,695...88,971,301
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
Sulindac inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; Sulindac inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]; Sulindac inhibits the reaction [TNF protein results in increased activity of RELA protein]; Sulindac inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Sulindac inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Sulindac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] [Sulindac co-treated with Lipopolysaccharides] results in increased secretion of TNF protein; Sulindac inhibits the reaction [Okadaic Acid results in increased expression of TNF protein] Sulindac results in increased expression of TNF
CTD
PMID:10328874 PMID:10757128 PMID:15489888 PMID:16159934 PMID:17328244 PMID:24136188 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
increases response to substance multiple interactions
ISO
Sulindac results in increased susceptibility to TNFSF10 protein [Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; TCF4 protein promotes the reaction [Sulindac results in increased susceptibility to TNFSF10 protein]
CTD
PMID:21171083
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tns3
tensin 3
decreases expression
ISO
Sulindac results in decreased expression of TNS3 mRNA
CTD
PMID:11906190
NCBI chr14:83,173,649...83,405,671
Ensembl chr14:83,173,649...83,405,998
G
Tor1a
torsin family 1, member A
decreases expression
EXP
Sulindac results in decreased expression of TOR1A mRNA
CTD
PMID:24136188
NCBI chr 3:14,250,667...14,257,704
Ensembl chr 3:14,250,676...14,257,691
G
Tp53
tumor protein p53
multiple interactions affects localization increases expression decreases expression
ISO
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased activity of TP53 protein; SB 203580 inhibits the reaction [Sulindac affects the localization of TP53 protein] Sulindac results in increased expression of TP53 protein Sulindac results in decreased expression of TRP53 protein
CTD
PMID:15020200 PMID:15713900 PMID:17136320
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tpra1
transmembrane protein adipocyte associated 1
increases expression
ISO
Sulindac results in increased expression of TPRA1 mRNA
CTD
PMID:11906190
NCBI chr 4:121,364,093...121,375,275
Ensembl chr 4:121,364,091...121,375,269
G
Trim2
tripartite motif-containing 2
increases expression
ISO
Sulindac results in increased expression of TRIM2 mRNA
CTD
PMID:11906190
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trit1
tRNA isopentenyltransferase 1
decreases expression
ISO
Sulindac results in decreased expression of TRIT1 mRNA
CTD
PMID:11906190
NCBI chr 5:135,293,472...135,341,522
Ensembl chr 5:135,295,330...135,338,764
G
Trub2
TruB pseudouridine synthase family member 2
increases expression
EXP
Sulindac results in increased expression of TRUB2 mRNA
CTD
PMID:24136188
NCBI chr 3:13,049,220...13,059,836
Ensembl chr 3:13,033,745...13,059,930
G
Tsnax
translin-associated factor X
decreases expression
ISO
Sulindac results in decreased expression of TSNAX mRNA
CTD
PMID:11906190
NCBI chr19:52,975,848...52,989,886
Ensembl chr19:52,975,659...52,989,878
G
Tusc2
tumor suppressor 2, mitochondrial calcium regulator
increases expression
EXP
Sulindac results in increased expression of TUSC2 mRNA
CTD
PMID:24136188
NCBI chr 8:117,115,479...117,118,697
Ensembl chr 8:108,236,838...108,240,056
G
Txn1
thioredoxin 1
increases response to substance
ISO
TXN1 results in increased susceptibility to Sulindac analog
CTD
PMID:18922898
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txnl1
thioredoxin-like 1
increases expression
EXP
Sulindac results in increased expression of TXNL1 mRNA
CTD
PMID:24136188
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
G
Tyw1
tRNA-yW synthesizing protein 1 homolog
increases expression
EXP
Sulindac results in increased expression of TYW1 mRNA
CTD
PMID:24136188
NCBI chr12:26,332,020...26,418,286
Ensembl chr12:26,330,351...26,418,208
G
Ube2e3
ubiquitin-conjugating enzyme E2E 3
decreases expression
EXP
Sulindac results in decreased expression of UBE2E3 mRNA
CTD
PMID:24136188
NCBI chr 3:63,786,976...63,851,400
Ensembl chr 3:63,786,650...63,843,237
G
Ube3a
ubiquitin protein ligase E3A
increases expression
EXP
Sulindac results in increased expression of UBE3A mRNA
CTD
PMID:24136188
NCBI chr 1:110,070,260...110,161,675
Ensembl chr 1:110,070,480...110,157,250
G
Ubl5
ubiquitin-like 5
decreases expression
EXP
Sulindac results in decreased expression of UBL5 mRNA
CTD
PMID:24136188
NCBI chr 8:19,181,504...19,185,224
Ensembl chr 8:19,181,615...19,185,217
G
Ubqln2
ubiquilin 2
increases expression
EXP
Sulindac results in increased expression of UBQLN2 mRNA
CTD
PMID:24136188
NCBI chr X:17,853,086...17,856,505
Ensembl chr X:17,853,114...17,856,505
G
Ufd1
ubiquitin recognition factor in ER associated degradation 1
decreases expression
EXP
Sulindac results in decreased expression of UFD1 mRNA
CTD
PMID:24136188
NCBI chr11:95,665,971...95,689,423
Ensembl chr11:82,161,619...82,185,087
G
Ufl1
Ufm1-specific ligase 1
increases expression
EXP
Sulindac results in increased expression of UFL1 mRNA
CTD
PMID:24136188
NCBI chr 5:38,962,721...38,995,134
Ensembl chr 5:38,962,171...38,995,199
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
increases expression
ISO
Sulindac results in increased expression of UGGT2 mRNA
CTD
PMID:11906190
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases activity increases expression increases glucuronidation
ISO
Sulindac results in increased activity of UGT1A1 protein Sulindac results in increased expression of UGT1A1 mRNA UGT1A1 protein results in increased glucuronidation of Sulindac
CTD
PMID:15843492 PMID:17985343
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Sulindac
CTD
PMID:15843492
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
increases glucuronidation
ISO
UGT1A4 protein results in increased glucuronidation of Sulindac
CTD
PMID:15843492
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases glucuronidation
ISO
UGT2B7 protein results in increased glucuronidation of Sulindac
CTD
PMID:15843492
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
Sulindac results in decreased expression of UNG mRNA
CTD
PMID:11906190
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:42,485,276...42,494,206
G
Uqcc2
ubiquinol-cytochrome c reductase complex assembly factor 2
decreases expression
EXP
Sulindac results in decreased expression of UQCC2 mRNA
CTD
PMID:24136188
NCBI chr20:5,202,837...5,214,541
Ensembl chr20:5,202,837...5,214,164 Ensembl chr17:5,202,837...5,214,164
G
Uqcc4
ubiquinol-cytochrome c reductase complex assembly factor 4
increases expression
EXP
Sulindac results in increased expression of UQCC4 mRNA
CTD
PMID:24136188
NCBI chr10:14,202,217...14,203,519
Ensembl chr10:14,202,243...14,204,029
G
Vapb
VAMP associated protein B and C
increases expression
EXP
Sulindac results in increased expression of VAPB mRNA
CTD
PMID:24136188
NCBI chr 3:182,954,247...182,997,018
Ensembl chr 3:162,535,905...162,573,763
G
Vash1
vasohibin 1
decreases expression
EXP
Sulindac results in decreased expression of VASH1 mRNA
CTD
PMID:24136188
NCBI chr 6:106,330,374...106,345,740
Ensembl chr 6:106,329,123...106,345,726
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of VCAM1 mRNA
CTD
PMID:20371263
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vcp
valosin-containing protein
decreases expression
EXP
Sulindac results in decreased expression of VCP mRNA
CTD
PMID:24136188
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:57,210,168...57,229,571
G
Vps26b
VPS26 retromer complex component B
decreases expression
EXP
Sulindac results in decreased expression of VPS26B mRNA
CTD
PMID:24136188
NCBI chr 8:25,415,877...25,436,985
Ensembl chr 8:25,415,261...25,436,985
G
Vps26c
VPS26 endosomal protein sorting factor C
increases expression
EXP
Sulindac results in increased expression of VPS26C mRNA
CTD
PMID:24136188
NCBI chr11:33,813,467...33,841,883
Ensembl chr11:33,792,389...33,841,447
G
Vps29
VPS29 retromer complex component
increases expression
EXP
Sulindac results in increased expression of VPS29 mRNA
CTD
PMID:24136188
NCBI chr12:34,208,911...34,217,977
Ensembl chr12:34,207,263...34,217,964
G
Vps35
VPS35 retromer complex component
decreases expression
EXP
Sulindac results in decreased expression of VPS35 mRNA
CTD
PMID:24136188
NCBI chr19:37,938,989...37,974,887
Ensembl chr19:21,765,749...21,801,618
G
Vps53
VPS53 subunit of GARP complex
increases expression
EXP
Sulindac results in increased expression of VPS53 mRNA
CTD
PMID:24136188
NCBI chr10:60,919,820...61,038,674
Ensembl chr10:60,919,820...61,038,676
G
Wdr3
WD repeat domain 3
increases expression
ISO
Sulindac results in increased expression of WDR3 mRNA
CTD
PMID:11906190
NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432
G
Wdr83os
WD repeat domain 83 opposite strand
increases expression
EXP
Sulindac results in increased expression of WDR83OS mRNA
CTD
PMID:24136188
NCBI chr19:23,075,373...23,076,745
Ensembl chr19:23,075,376...23,076,894
G
Wwp1
WW domain containing E3 ubiquitin protein ligase 1
decreases expression
EXP
Sulindac results in decreased expression of WWP1 mRNA
CTD
PMID:24136188
NCBI chr 5:33,092,379...33,185,887
Ensembl chr 5:33,098,494...33,186,046
G
Xbp1
X-box binding protein 1
increases expression
ISO
Sulindac results in increased expression of XBP1 mRNA
CTD
PMID:11906190
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
[Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of XIAP protein
CTD
PMID:17136320
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xpo1
exportin 1
multiple interactions
EXP
[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of XPO1 mRNA
CTD
PMID:20371263
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:97,233,270...97,275,498
G
Xpr1
xenotropic and polytropic retrovirus receptor 1
increases expression
EXP
Sulindac results in increased expression of XPR1 mRNA
CTD
PMID:24136188
NCBI chr13:67,441,205...67,585,950
Ensembl chr13:67,446,380...67,585,946
G
Xrcc5
X-ray repair cross complementing 5
decreases expression
EXP
Sulindac results in decreased expression of XRCC5 mRNA
CTD
PMID:24136188
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
G
Yme1l1
YME1-like 1 ATPase
decreases expression
EXP
Sulindac results in decreased expression of YME1L1 mRNA
CTD
PMID:24136188
NCBI chr17:85,287,607...85,326,068
Ensembl chr17:85,287,554...85,326,335
G
Ythdf3
YTH N6-methyladenosine RNA binding protein F3
increases expression
EXP
Sulindac results in increased expression of YTHDF3 mRNA
CTD
PMID:24136188
NCBI chr 2:100,266,942...100,300,896
Ensembl chr 2:98,350,588...98,384,606
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
increases expression
EXP
Sulindac results in increased expression of YWHAB mRNA
CTD
PMID:24136188
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
increases expression
EXP
Sulindac results in increased expression of YWHAE mRNA
CTD
PMID:24136188
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
G
Zc3h13
zinc finger CCCH type containing 13
increases expression
EXP
Sulindac results in increased expression of ZC3H13 mRNA
CTD
PMID:24136188
NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
G
Zfp106
zinc finger protein 106
decreases expression
EXP
Sulindac results in decreased expression of ZFP106 mRNA
CTD
PMID:24136188
NCBI chr 3:107,459,232...107,510,507
Ensembl chr 3:107,462,096...107,510,481
G
Zfp148
zinc finger protein 148
decreases expression
EXP
Sulindac results in decreased expression of ZFP148 mRNA
CTD
PMID:24136188
NCBI chr11:67,276,455...67,385,803
Ensembl chr11:67,281,707...67,385,772
G
Zfp281
zinc finger protein 281
increases expression
EXP
Sulindac results in increased expression of ZFP281 mRNA
CTD
PMID:24136188
NCBI chr13:48,096,103...48,104,265
Ensembl chr13:48,037,286...48,104,888
G
Zfp354a
zinc finger protein 354A
increases expression
ISO
Sulindac results in increased expression of ZNF354A mRNA
CTD
PMID:11906190
NCBI chr10:35,396,242...35,408,069
Ensembl chr10:35,396,231...35,408,068
G
Zfp423
zinc finger protein 423
decreases expression
EXP
Sulindac results in decreased expression of ZFP423 mRNA
CTD
PMID:24136188
NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373
G
Znhit1
zinc finger, HIT-type containing 1
increases expression
EXP
Sulindac results in increased expression of ZNHIT1 mRNA
CTD
PMID:24136188
NCBI chr12:25,323,292...25,329,566
Ensembl chr12:19,686,148...19,692,880
G
Znhit3
zinc finger, HIT-type containing 3
increases expression
EXP
Sulindac results in increased expression of ZNHIT3 mRNA
CTD
PMID:24136188
NCBI chr10:69,775,885...69,790,471
Ensembl chr10:69,748,789...69,790,475 Ensembl chr10:69,748,789...69,790,475
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
sulindac sulfide results in increased expression of ABCG2 mRNA
CTD
PMID:16184548
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
G
Actn1
actinin, alpha 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ACTN1 mRNA
CTD
PMID:16184548
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Adam9
ADAM metallopeptidase domain 9
decreases expression
ISO
sulindac sulfide results in decreased expression of ADAM9 mRNA
CTD
PMID:16184548
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adm
adrenomedullin
increases expression
ISO
sulindac sulfide results in increased expression of ADM mRNA
CTD
PMID:16184548
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adra2c
adrenoceptor alpha 2C
decreases expression
ISO
sulindac sulfide results in decreased expression of ADRA2C mRNA
CTD
PMID:12734198
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:75,471,143...75,472,846
G
Ahr
aryl hydrocarbon receptor
increases localization
ISO
sulindac sulfide results in increased localization of AHR protein
CTD
PMID:17985343
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akap12
A-kinase anchoring protein 12
increases expression
ISO
sulindac sulfide results in increased expression of AKAP12 mRNA
CTD
PMID:12734198
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
sulindac sulfide results in increased expression of AKR1C1 mRNA
CTD
PMID:16184548
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Aldoc
aldolase, fructose-bisphosphate C
decreases expression
ISO
sulindac sulfide results in decreased expression of ALDOC mRNA
CTD
PMID:16184548
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,217,451...63,221,066
G
Alox15
arachidonate 15-lipoxygenase
increases expression
ISO
sulindac sulfide results in increased expression of ALOX15 protein
CTD
PMID:16166323
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
G
Anxa5
annexin A5
increases expression
ISO
sulindac sulfide results in increased expression of ANXA5 protein
CTD
PMID:18678619
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:119,314,007...119,353,369
G
Apoa1
apolipoprotein A1
multiple interactions
ISO
sulindac sulfide inhibits the reaction [Phosphatidylinositols results in increased expression of APOA1 protein]
CTD
PMID:19013290
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
App
amyloid beta precursor protein
multiple interactions affects cleavage
ISO EXP
[sulindac sulfide results in decreased activity of PSEN1 protein] which affects the cleavage of APP protein; PSEN1 protein affects the reaction [sulindac sulfide affects the cleavage of APP protein]; PSEN1 protein mutant form promotes the reaction [sulindac sulfide affects the cleavage of APP protein]; sulindac sulfide affects the cleavage of and affects the localization of APP protein; sulindac sulfide affects the reaction [PSEN1 protein affects the cleavage of APP protein] sulindac sulfide inhibits the reaction [APP protein results in increased uptake of Calcium]
CTD
PMID:11700559 PMID:12637581 PMID:12777371 PMID:12805356 PMID:14690522 PMID:15274632 PMID:17573346 PMID:17962197 PMID:18359496 PMID:18426795 PMID:18648507 More...
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Ar
androgen receptor
multiple interactions
ISO
AR protein affects the reaction [sulindac sulfide results in decreased expression of KLK3 protein]; sulindac sulfide results in decreased expression of and results in decreased activity of AR protein
CTD
PMID:14581372
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
increases expression
ISO
sulindac sulfide results in increased expression of AREG mRNA
CTD
PMID:16184548
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ARL6IP1 mRNA
CTD
PMID:12734198
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
decreases expression
ISO
sulindac sulfide results in decreased expression of ARPC1B mRNA
CTD
PMID:12734198
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:9,480,831...9,495,747
G
Asah1
N-acylsphingosine amidohydrolase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ASAH1 mRNA
CTD
PMID:16184548
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Atf3
activating transcription factor 3
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein; [sulindac sulfide results in increased phosphorylation of MAPK3 protein] which results in increased expression of ATF3 protein; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; MAP2K1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA] sulindac sulfide results in increased expression of ATF3 mRNA; sulindac sulfide results in increased expression of ATF3 protein
CTD
PMID:12734198 PMID:15897233 PMID:16079301 PMID:16184548 PMID:21554132 PMID:24440808 More...
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atp6v0a1
ATPase H+ transporting V0 subunit a1
increases expression
ISO
sulindac sulfide results in increased expression of ATP6V0A1 mRNA
CTD
PMID:16184548
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:85,935,854...85,989,895
G
Aurka
aurora kinase A
decreases expression
ISO
sulindac sulfide results in decreased expression of AURKA mRNA
CTD
PMID:12734198
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Bad
BCL2-associated agonist of cell death
decreases expression increases localization multiple interactions
ISO
sulindac sulfide results in decreased expression of BAD protein sulindac sulfide results in increased localization of BAD protein [sulindac sulfide results in decreased expression of YWHAE protein] which results in increased localization of BAD protein; sulindac sulfide promotes the reaction [BAD protein binds to YWHAE protein]
CTD
PMID:17409426 PMID:18678619
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
increases response to substance
EXP
BAK1 results in increased susceptibility to sulindac sulfide
CTD
PMID:18349538
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression decreases expression affects response to substance
ISO
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]] sulindac sulfide results in increased expression of BAX mRNA sulindac sulfide results in decreased expression of BAX protein BAX protein affects the susceptibility to sulindac sulfide
CTD
PMID:12203115 PMID:16886631
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcam
basal cell adhesion molecule (Lutheran blood group)
decreases expression
ISO
sulindac sulfide results in decreased expression of BCAM mRNA
CTD
PMID:12734198
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
G
Bcar1
BCAR1 scaffold protein, Cas family member
decreases phosphorylation
ISO
sulindac sulfide results in decreased phosphorylation of BCAR1 protein
CTD
PMID:10741720
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
sulindac sulfide results in decreased expression of BCL2 protein
CTD
PMID:18678619
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
sulindac sulfide results in decreased expression of BCL2L1 protein
CTD
PMID:11912124
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bid
BH3 interacting domain death agonist
decreases expression increases cleavage
ISO
sulindac sulfide results in decreased expression of BID protein sulindac sulfide results in increased cleavage of BID protein
CTD
PMID:12203115 PMID:16886631
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
sulindac sulfide results in increased expression of BIRC3 mRNA
CTD
PMID:16184548
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
sulindac sulfide results in decreased expression of BUB1B mRNA
CTD
PMID:16184548
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:105,563,138...105,615,547
G
Cacng3
calcium voltage-gated channel auxiliary subunit gamma 3
increases expression
ISO
sulindac sulfide results in increased expression of CACNG3 mRNA
CTD
PMID:16184548
NCBI chr 1:186,632,334...186,728,220
Ensembl chr 1:177,201,288...177,297,024
G
Casp3
caspase 3
increases activity increases expression multiple interactions
ISO
sulindac sulfide results in increased activity of CASP3 protein sulindac sulfide results in increased expression of CASP3 mRNA [sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]]; MAP2K1 protein inhibits the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP3 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein]; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]
CTD
PMID:11051267 PMID:12203115 PMID:12414664 PMID:14555707 PMID:15548677 PMID:16886631 PMID:20371263 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein]
CTD
PMID:20371263
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions increases activity
ISO
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP8 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]
CTD
PMID:11559570 PMID:12203115 PMID:12414664 PMID:16886631
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases activity
ISO
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP9 protein]; sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]
CTD
PMID:12203115 PMID:12414664
Ensembl chr 5:154,109,046...154,126,626
G
Ccar1
cell division cycle and apoptosis regulator 1
increases expression
ISO
sulindac sulfide results in increased expression of CCAR1 mRNA
CTD
PMID:12734198
NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
G
Ccn2
cellular communication network factor 2
decreases expression increases expression
ISO
sulindac sulfide results in decreased expression of CCN2 mRNA sulindac sulfide results in increased expression of CCN2 mRNA
CTD
PMID:12734198 PMID:16184548
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Ccnd1
cyclin D1
multiple interactions decreases expression
ISO
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of CCND1 protein] sulindac sulfide results in decreased expression of CCND1 mRNA; sulindac sulfide results in decreased expression of CCND1 protein
CTD
PMID:14710233 PMID:15188006 PMID:15767558
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cd4
Cd4 molecule
increases expression
ISO
sulindac sulfide results in increased expression of CD4 mRNA
CTD
PMID:12734198
NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:157,668,878...157,695,191
G
Cd46
CD46 molecule
decreases expression
ISO
sulindac sulfide results in decreased expression of CD46 mRNA
CTD
PMID:16184548
NCBI chr13:109,104,122...109,134,903
Ensembl chr13:106,574,858...106,660,445
G
Cdh1
cadherin 1
multiple interactions
ISO
sulindac sulfide results in increased expression of and results in increased activity of CDH1 protein
CTD
PMID:12391285
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdh17
cadherin 17
decreases expression
ISO
sulindac sulfide results in decreased expression of CDH17 mRNA
CTD
PMID:16184548
NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:25,262,758...25,314,884
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions affects activity increases expression
ISO
PPARD protein inhibits the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]; PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA] sulindac sulfide affects the activity of CDKN1A protein sulindac sulfide results in increased expression of CDKN1A mRNA; sulindac sulfide results in increased expression of CDKN1A protein
CTD
PMID:15694660 PMID:15767558 PMID:16091736 PMID:16184548
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
sulindac sulfide results in increased expression of CEBPB mRNA; sulindac sulfide results in increased expression of CEBPB protein
CTD
PMID:12734198 PMID:16184548
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Cflar
CASP8 and FADD-like apoptosis regulator
decreases expression
ISO
sulindac sulfide results in decreased expression of CFLAR protein
CTD
PMID:11912124
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Clp1
cleavage factor polyribonucleotide kinase subunit 1
decreases expression
ISO
sulindac sulfide results in decreased expression of CLP1 mRNA
CTD
PMID:12734198
NCBI chr 3:69,806,774...69,818,633
Ensembl chr 3:69,806,778...69,810,421
G
Cryab
crystallin, alpha B
increases expression
ISO
sulindac sulfide results in increased expression of CRYAB mRNA
CTD
PMID:16184548
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:51,093,441...51,099,157
G
Ctnnb1
catenin beta 1
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein]; sulindac sulfide affects the localization of and results in decreased expression of CTNNB1 protein; sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of CCND1 protein]; sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein]; sulindac sulfide results in decreased expression of and results in decreased localization of CTNNB1 protein
CTD
PMID:14555707 PMID:14710233 PMID:15188006
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctsc
cathepsin C
decreases expression
ISO
sulindac sulfide results in decreased expression of CTSC mRNA
CTD
PMID:16184548
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:142,028,392...142,060,387
G
Cyb5b
cytochrome b5 type B
decreases expression
ISO
sulindac sulfide results in decreased expression of CYB5B mRNA
CTD
PMID:12734198
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:35,062,813...35,098,249
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
sulindac sulfide results in increased expression of CYP1A1 mRNA
CTD
PMID:12734198 PMID:16184548 PMID:17985343
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO
sulindac sulfide results in increased expression of CYP1A2 mRNA
CTD
PMID:17985343
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
sulindac sulfide results in increased expression of CYP1B1 mRNA
CTD
PMID:12734198 PMID:17985343
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Dcbld2
discoidin, CUB and LCCL domain containing 2
increases expression
ISO
sulindac sulfide results in increased expression of DCBLD2 mRNA
CTD
PMID:12734198
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
G
Ddx11
DEAD/H-box helicase 11
decreases expression
ISO
sulindac sulfide results in decreased expression of DDX11 mRNA
CTD
PMID:16184548
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:105,833,504...105,862,550
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
sulindac sulfide results in decreased expression of DHCR24 mRNA
CTD
PMID:16184548
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:121,344,575...121,371,137
G
Dhcr7
7-dehydrocholesterol reductase
decreases expression
ISO
sulindac sulfide results in decreased expression of DHCR7 mRNA
CTD
PMID:16184548
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
sulindac sulfide results in decreased expression of DYNLL1 mRNA
CTD
PMID:12734198
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Egfr
epidermal growth factor receptor
multiple interactions decreases expression increases ubiquitination increases phosphorylation decreases phosphorylation
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfide results in decreased expression of EGFR protein] sulindac sulfide results in increased ubiquitination of EGFR protein sulindac sulfide results in increased phosphorylation of EGFR protein sulindac sulfide results in decreased phosphorylation of EGFR protein
CTD
PMID:20332299
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
multiple interactions increases expression
ISO
EGR1 protein affects the reaction [sulindac sulfide results in increased expression of THBS1 mRNA]; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]; EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of GDF15 mRNA]; ELK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; U 0126 inhibits the reaction [sulindac sulfide results in increased expression of EGR1 mRNA] sulindac sulfide results in increased expression of EGR1 mRNA; sulindac sulfide results in increased expression of EGR1 protein
CTD
PMID:15509713 PMID:16079301 PMID:16227405 PMID:17599376
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Elk1
ETS transcription factor ELK1
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; ELK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; sulindac sulfide results in increased phosphorylation of and affects the activity of ELK1 protein; U 0126 inhibits the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]
CTD
PMID:17599376
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:1,139,756...1,155,713
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of ERBB2 protein]
CTD
PMID:20332299
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of ERBB3 protein]
CTD
PMID:20332299
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
affects cleavage
ISO
sulindac sulfide affects the cleavage of ERBB4 protein
CTD
PMID:12777371
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Esd
esterase D
increases expression
ISO
sulindac sulfide results in increased expression of ESD mRNA
CTD
PMID:12734198
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Esr1
estrogen receptor 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ESR1 mRNA; sulindac sulfide results in decreased expression of ESR1 protein
CTD
PMID:16740773
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Etfb
electron transfer flavoprotein subunit beta
decreases expression
ISO
sulindac sulfide results in decreased expression of ETFB mRNA
CTD
PMID:16184548
NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:93,851,858...93,866,068
G
Etnppl
ethanolamine-phosphate phospho-lyase
increases expression
ISO
sulindac sulfide results in increased expression of ETNPPL mRNA
CTD
PMID:12734198
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
G
Fabp1
fatty acid binding protein 1
multiple interactions increases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]
CTD
PMID:17602619 PMID:18665581
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788
G
Fabp4
fatty acid binding protein 4
multiple interactions increases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]
CTD
PMID:17602619 PMID:18665581
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578
G
Fcgrt
Fc gamma receptor and transporter
decreases expression
ISO
sulindac sulfide results in decreased expression of FCGRT mRNA
CTD
PMID:16184548
NCBI chr 1:95,574,436...95,584,171
Ensembl chr 1:95,567,175...95,584,084
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
sulindac sulfide results in decreased expression of FDPS mRNA
CTD
PMID:16184548
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fgfr4
fibroblast growth factor receptor 4
decreases expression
ISO
sulindac sulfide results in decreased expression of FGFR4 mRNA
CTD
PMID:16184548
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,461,547...9,476,242
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
affects metabolic processing increases metabolic processing
ISO
FMO3 gene polymorphism affects the metabolism of sulindac sulfide FMO3 protein results in increased metabolism of sulindac sulfide
CTD
PMID:17142560 PMID:17559352
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Foxm1
forkhead box M1
decreases expression
ISO
sulindac sulfide results in decreased expression of FOXM1 mRNA
CTD
PMID:16184548
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Gal3st4
galactose-3-O-sulfotransferase 4
decreases expression
ISO
sulindac sulfide results in decreased expression of GAL3ST4 mRNA
CTD
PMID:16184548
NCBI chr12:17,267,963...17,276,951
Ensembl chr12:17,267,963...17,276,833
G
Gars1
glycyl-tRNA synthetase 1
increases expression
ISO
sulindac sulfide results in increased expression of GARS1 mRNA
CTD
PMID:12734198
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gdf15
growth differentiation factor 15
multiple interactions increases expression
ISO
EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of GDF15 mRNA] sulindac sulfide results in increased expression of GDF15 mRNA; sulindac sulfide results in increased expression of GDF15 protein
CTD
PMID:11895857 PMID:11925476 PMID:12734198 PMID:15180942 PMID:15509713 PMID:15555568 PMID:15767558 PMID:18076062 More...
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gk
glycerol kinase
increases expression
ISO
sulindac sulfide results in increased expression of GK mRNA
CTD
PMID:16184548
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Glcci1
glucocorticoid induced 1
increases expression
ISO
sulindac sulfide results in increased expression of GLCCI1 mRNA
CTD
PMID:16184548
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
G
Grn
granulin precursor
decreases expression
ISO
sulindac sulfide results in decreased expression of GRN mRNA
CTD
PMID:16184548
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
sulindac sulfide binds to and results in decreased activity of GSTP1 protein
CTD
PMID:15300575
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac1
histone deacetylase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of HDAC1 mRNA
CTD
PMID:16184548
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Hgf
hepatocyte growth factor
decreases expression
ISO
sulindac sulfide results in decreased expression of HGF mRNA
CTD
PMID:10807402
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:18,677,101...18,745,409
G
Hm13
histocompatibility minor 13
affects binding multiple interactions
ISO
sulindac sulfide binds to HM13 protein sulindac sulfide inhibits the reaction [L 685458 binds to HM13 protein]
CTD
PMID:17932033
NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:141,145,782...141,184,703
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of HSD3B1 mRNA
CTD
PMID:16184548
NCBI chr 2:188,858,574...188,864,694
Ensembl chr 2:186,169,863...186,175,999
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
sulindac sulfide results in increased expression of HSPA1B mRNA
CTD
PMID:16184548
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
sulindac sulfide results in increased expression of HSPA6 mRNA
CTD
PMID:16184548
NCBI chr13:85,805,911...85,807,052
G
Icam2
intercellular adhesion molecule 2
increases expression
ISO
sulindac sulfide results in increased expression of ICAM2 mRNA
CTD
PMID:16184548
NCBI chr10:91,808,449...91,819,319
Ensembl chr10:91,308,538...91,315,293
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ID1 mRNA; sulindac sulfide results in decreased expression of ID1 protein
CTD
PMID:16184548 PMID:21554132
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
sulindac sulfide results in decreased expression of IFITM1 mRNA
CTD
PMID:16184548
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm3
interferon induced transmembrane protein 3
decreases expression
ISO
sulindac sulfide results in decreased expression of IFITM3 mRNA
CTD
PMID:16184548
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifrd1
interferon-related developmental regulator 1
increases expression
ISO
sulindac sulfide results in increased expression of IFRD1 mRNA
CTD
PMID:12734198
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
decreases activity
ISO
sulindac sulfide results in decreased activity of IKBKB protein
CTD
PMID:11912124
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il13ra1
interleukin 13 receptor subunit alpha 1
decreases expression
ISO
sulindac sulfide results in decreased expression of IL13RA1 mRNA
CTD
PMID:16184548
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO
sulindac sulfide results in increased expression of IL1R1 mRNA
CTD
PMID:16184548
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:42,504,735...42,579,937
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
sulindac sulfide results in decreased expression of ILF3 mRNA
CTD
PMID:16184548
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
G
Insig1
insulin induced gene 1
decreases expression
ISO
sulindac sulfide results in decreased expression of INSIG1 mRNA
CTD
PMID:12734198
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
sulindac sulfide results in increased expression of ISG20 mRNA
CTD
PMID:16184548
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
decreases expression
ISO
sulindac sulfide results in decreased expression of ITPR1 mRNA
CTD
PMID:15767558
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:141,187,418...141,510,491
G
Jag2
jagged canonical Notch ligand 2
increases expression
ISO
sulindac sulfide results in increased expression of JAG2 mRNA
CTD
PMID:16184548
NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:131,983,056...132,005,818
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
sulindac sulfide results in increased expression of JUN mRNA
CTD
PMID:16704987
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kalrn
kalirin, RhoGEF kinase
decreases expression
ISO
sulindac sulfide results in decreased expression of KALRN mRNA
CTD
PMID:16184548
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
G
Klhl21
kelch-like family member 21
increases expression
ISO
sulindac sulfide results in increased expression of KLHL21 mRNA
CTD
PMID:16184548
NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression multiple interactions
ISO
sulindac sulfide results in decreased expression of KLK3 protein AR protein affects the reaction [sulindac sulfide results in decreased expression of KLK3 protein]
CTD
PMID:14581372
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052
G
Krt14
keratin 14
increases expression
ISO
sulindac sulfide results in increased expression of KRT14 mRNA
CTD
PMID:16184548
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
G
Krt16
keratin 16
increases expression
ISO
sulindac sulfide results in increased expression of KRT16 mRNA
CTD
PMID:16184548
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Krt17
keratin 17
increases expression
ISO
sulindac sulfide results in increased expression of KRT17 mRNA
CTD
PMID:16184548
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
G
Krt19
keratin 19
decreases expression
ISO
sulindac sulfide results in decreased expression of KRT19 mRNA
CTD
PMID:12734198
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt5
keratin 5
decreases expression
ISO
sulindac sulfide results in decreased expression of KRT5 mRNA
CTD
PMID:12734198
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Lamc1
laminin subunit gamma 1
increases expression decreases expression
ISO
sulindac sulfide results in increased expression of LAMC1 mRNA sulindac sulfide results in decreased expression of LAMC1 protein
CTD
PMID:15561105 PMID:16184548
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
G
Lamp1
lysosomal-associated membrane protein 1
decreases expression
ISO
sulindac sulfide results in decreased expression of LAMP1 mRNA
CTD
PMID:16184548
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:76,355,984...76,381,883
G
Ldha
lactate dehydrogenase A
decreases expression
ISO
sulindac sulfide results in decreased expression of LDHA mRNA
CTD
PMID:12734198
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Ldlr
low density lipoprotein receptor
decreases expression
ISO
sulindac sulfide results in decreased expression of LDLR mRNA
CTD
PMID:16184548
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
sulindac sulfide results in decreased expression of MAD2L1 mRNA; sulindac sulfide results in decreased expression of MAD2L1 protein
CTD
PMID:12734198
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:95,906,817...95,913,470
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
increases expression
ISO
sulindac sulfide results in increased expression of MAGI1 mRNA
CTD
PMID:12734198
NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
sulindac sulfide results in decreased expression of MAL mRNA
CTD
PMID:16184548
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Man2b2
mannosidase, alpha, class 2B, member 2
increases expression
ISO
sulindac sulfide results in increased expression of MAN2B2 mRNA
CTD
PMID:12734198
NCBI chr14:73,969,079...73,994,089
Ensembl chr14:73,969,003...74,004,281
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
sulindac sulfide results in increased expression of MANF mRNA
CTD
PMID:16184548
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK3 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]; MAP2K1 protein promotes the reaction [sulindac sulfide results in increased expression of ATF3 mRNA]
CTD
PMID:15548677 PMID:16079301
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of MAP3K1 mRNA
CTD
PMID:12734198
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation decreases phosphorylation
ISO
[sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein; [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of THBS1 protein; MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK1 protein]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK1 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; sulindac sulfide results in increased phosphorylation of and affects the activity of MAPK1 protein
CTD
PMID:15548677 PMID:16079301 PMID:17599376 PMID:18261746
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk10
mitogen activated protein kinase 10
increases expression
ISO
sulindac sulfide results in increased expression of MAPK10 mRNA
CTD
PMID:12734198
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,497,707...6,786,201
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation decreases phosphorylation
ISO
[sulindac sulfide results in increased phosphorylation of MAPK3 protein] which results in increased expression of ATF3 protein; [sulindac sulfide results in increased phosphorylation of MAPK3 protein] which results in increased expression of THBS1 protein; MAP2K1 protein inhibits the reaction [sulindac sulfide results in decreased phosphorylation of MAPK3 protein]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased expression of EGR1 mRNA]; MAPK3 protein promotes the reaction [sulindac sulfide results in increased phosphorylation of and results in increased activity of ELK1 protein]; sulindac sulfide results in increased phosphorylation of and affects the activity of MAPK3 protein
CTD
PMID:15548677 PMID:16079301 PMID:17599376 PMID:18261746
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases activity
ISO
sulindac sulfide results in increased activity of MAPK8 protein
CTD
PMID:11051267
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mars2
methionyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
sulindac sulfide results in increased expression of MARS2 mRNA
CTD
PMID:16184548
NCBI chr 9:56,720,408...56,729,991
Ensembl chr 9:56,720,983...56,723,820
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
sulindac sulfide results in decreased expression of MCM2 mRNA
CTD
PMID:16184548
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847
G
Met
MET proto-oncogene, receptor tyrosine kinase
multiple interactions
ISO
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein]
CTD
PMID:14710233
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mmp1
matrix metallopeptidase 1
decreases expression increases expression
ISO
sulindac sulfide results in decreased expression of MMP1 mRNA sulindac sulfide results in increased expression of MMP1 mRNA
CTD
PMID:15767558 PMID:16184548
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp10
matrix metallopeptidase 10
increases expression
ISO
sulindac sulfide results in increased expression of MMP10 mRNA
CTD
PMID:16184548
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mras
muscle RAS oncogene homolog
increases expression
ISO
sulindac sulfide results in increased expression of MRAS mRNA
CTD
PMID:16184548
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:99,944,036...99,996,408
G
Msmo1
methylsterol monooxygenase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of MSMO1 mRNA
CTD
PMID:12734198
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
G
Msx1
msh homeobox 1
decreases expression
ISO
sulindac sulfide results in decreased expression of MSX1 mRNA; sulindac sulfide results in decreased expression of MSX1 protein
CTD
PMID:12734198
NCBI chr14:77,185,802...77,189,735
Ensembl chr14:72,961,148...72,964,966
G
Mtfr1
mitochondrial fission regulator 1
increases expression
ISO
sulindac sulfide results in increased expression of MTFR1 mRNA
CTD
PMID:16184548
NCBI chr 2:101,678,331...101,713,547
Ensembl chr 2:101,679,265...101,713,544
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
ISO
sulindac sulfide results in increased expression of MTHFD2 mRNA
CTD
PMID:12734198
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
sulindac sulfide results in decreased expression of MUC1 mRNA
CTD
PMID:16184548
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Mx1
MX dynamin like GTPase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of MX1 mRNA
CTD
PMID:16184548
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Myh10
myosin heavy chain 10
increases expression
ISO
sulindac sulfide results in increased expression of MYH10 mRNA
CTD
PMID:12734198
NCBI chr10:53,393,901...53,525,174
Ensembl chr10:53,394,389...53,525,165
G
Ncapd3
non-SMC condensin II complex, subunit D3
decreases expression
ISO
sulindac sulfide results in decreased expression of NCAPD3 mRNA
CTD
PMID:16184548
NCBI chr 8:33,696,214...33,765,520
Ensembl chr 8:25,437,123...25,506,373
G
Nfkb1
nuclear factor kappa B subunit 1
decreases activity
ISO
sulindac sulfide results in decreased activity of NFKB1 protein
CTD
PMID:12085227
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
decreases phosphorylation
ISO
sulindac sulfide results in decreased phosphorylation of NFKBIA protein
CTD
PMID:12085227
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Niban1
niban apoptosis regulator 1
increases expression
ISO
sulindac sulfide results in increased expression of NIBAN1 mRNA
CTD
PMID:12734198
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases activity increases expression
ISO
sulindac sulfide results in increased activity of NQO1 protein sulindac sulfide results in increased expression of NQO1 mRNA
CTD
PMID:17985343
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nup133
nucleoporin 133
increases expression
ISO
sulindac sulfide results in increased expression of NUP133 mRNA
CTD
PMID:12734198
NCBI chr19:51,891,606...51,941,243
Ensembl chr19:51,891,629...51,941,239
G
Odc1
ornithine decarboxylase 1
increases expression
ISO
sulindac sulfide results in increased expression of ODC1 mRNA
CTD
PMID:16184548
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions decreases expression increases cleavage
ISO
(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid promotes the reaction [sulindac sulfide results in increased cleavage of PARP1 protein] sulindac sulfide results in decreased expression of PARP1 mRNA
CTD
PMID:12663503 PMID:16184548 PMID:16886631 PMID:18678619 PMID:21400612
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
increases expression
ISO
sulindac sulfide results in increased expression of PAWR mRNA
CTD
PMID:10833474
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
sulindac sulfide results in decreased expression of PCSK9 mRNA
CTD
PMID:16184548
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
G
Pgam1
phosphoglycerate mutase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of PGAM1 mRNA
CTD
PMID:12734198
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgr
progesterone receptor
decreases expression
ISO
sulindac sulfide results in decreased expression of PGR mRNA; sulindac sulfide results in decreased expression of PGR protein
CTD
PMID:16740773
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
G
Pkm
pyruvate kinase M1/2
decreases expression
ISO
sulindac sulfide results in decreased expression of PKM mRNA
CTD
PMID:16184548
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
sulindac sulfide results in decreased expression of PLAU mRNA
CTD
PMID:15767558
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
sulindac sulfide results in increased expression of PMAIP1 mRNA
CTD
PMID:16184548
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
G
Pold3
DNA polymerase delta 3, accessory subunit
decreases expression
ISO
sulindac sulfide results in decreased expression of POLD3 mRNA
CTD
PMID:16184548
NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
ISO
sulindac sulfide results in increased expression of PPARA mRNA
CTD
PMID:11948457
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
multiple interactions increases expression decreases activity decreases expression
ISO
PPARD protein affects the reaction [sulindac sulfide results in decreased expression of YWHAE protein]; PPARD protein inhibits the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]; sulindac sulfide binds to and results in decreased activity of PPARD protein sulindac sulfide results in increased expression of PPARD mRNA; sulindac sulfide results in increased expression of PPARD protein sulindac sulfide results in decreased activity of PPARD protein sulindac sulfide results in decreased expression of PPARD mRNA; sulindac sulfide results in decreased expression of PPARD protein
CTD
PMID:10555149 PMID:11948457 PMID:16091736 PMID:17409426 PMID:18678619 PMID:21400612 More...
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression increases activity affects binding
ISO
[sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]; PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]; PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]; sulindac sulfide analog binds to and results in increased activity of PPARG protein; sulindac sulfide analog inhibits the reaction [troglitazone binds to PPARG protein]; sulindac sulfide binds to and results in increased activity of PPARG protein sulindac sulfide results in increased expression of PPARG mRNA sulindac sulfide analog binds to PPARG protein
CTD
PMID:10866999 PMID:11948457 PMID:16091736 PMID:17602619 PMID:18665581
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
decreases expression
ISO
sulindac sulfide results in decreased expression of PPP2R1A mRNA
CTD
PMID:12734198
NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:60,540,194...60,560,129
G
Ppt1
palmitoyl-protein thioesterase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of PPT1 mRNA
CTD
PMID:16184548
NCBI chr 5:140,406,318...140,427,201
Ensembl chr 5:135,121,163...135,142,048
G
Prep
prolyl endopeptidase
increases expression
ISO
sulindac sulfide results in increased expression of PREP mRNA
CTD
PMID:12734198
NCBI chr20:48,556,211...48,653,165
Ensembl chr20:48,556,280...48,654,466
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
increases expression
ISO
sulindac sulfide results in increased expression of PRKACA mRNA
CTD
PMID:16184548
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430
G
Prkcsh
PRKCSH beta subunit of glucosidase II
decreases expression
ISO
sulindac sulfide results in decreased expression of PRKCSH mRNA
CTD
PMID:16184548
NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492
G
Prrx1
paired related homeobox 1
decreases expression
ISO
sulindac sulfide results in decreased expression of PRRX1 mRNA
CTD
PMID:16184548
NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
G
Prss23
serine protease 23
decreases expression
ISO
sulindac sulfide results in decreased expression of PRSS23 mRNA
CTD
PMID:12734198
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Psen1
presenilin 1
decreases response to substance decreases activity multiple interactions
ISO
PSEN1 gene mutant form results in decreased susceptibility to sulindac sulfide sulindac sulfide results in decreased activity of PSEN1 protein [sulindac sulfide results in decreased activity of PSEN1 protein] which affects the cleavage of APP protein; PSEN1 protein affects the reaction [sulindac sulfide affects the cleavage of APP protein]; PSEN1 protein mutant form promotes the reaction [sulindac sulfide affects the cleavage of APP protein]; sulindac sulfide affects the reaction [PSEN1 protein affects the cleavage of APP protein]
CTD
PMID:12805356 PMID:17573346 PMID:17962197
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:103,323,120...103,371,650
G
Psmc2
proteasome 26S subunit, ATPase 2
decreases expression
ISO
sulindac sulfide results in decreased expression of PSMC2 mRNA
CTD
PMID:16184548
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
G
Ptgdr2
prostaglandin D2 receptor 2
affects binding multiple interactions
ISO
sulindac sulfide binds to PTGDR2 protein [sulindac sulfide binds to PTGDR2 protein] which results in decreased abundance of Cyclic AMP; sulindac sulfide inhibits the reaction [Prostaglandin D2 binds to PTGDR2 protein]
CTD
PMID:15563582
NCBI chr 1:207,585,088...207,590,275
Ensembl chr 1:207,587,917...207,589,213
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases activity
ISO
sulindac sulfide results in decreased activity of PTGS1 protein
CTD
PMID:11245490
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression decreases activity increases response to substance
ISO
[sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP3 protein]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP8 protein]; PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP9 protein]; sulindac sulfide inhibits the reaction [PTGS2 protein results in decreased expression of TNFRSF10B mRNA]; sulindac sulfide inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] sulindac sulfide results in increased expression of PTGS2 mRNA; sulindac sulfide results in increased expression of PTGS2 protein sulindac sulfide results in decreased activity of PTGS2 protein PTGS2 protein results in increased susceptibility to sulindac sulfide
CTD
PMID:10485483 PMID:10866999 PMID:11245490 PMID:11948457 PMID:12208739 PMID:12414664 More...
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases phosphorylation
ISO
sulindac sulfide results in decreased phosphorylation of PTK2 protein
CTD
PMID:10741720
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
ISO
sulindac sulfide results in decreased expression of PTPRF mRNA
CTD
PMID:16184548
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:131,742,754...131,810,023
G
Pvt1
Pvt1 oncogene
increases expression
ISO
sulindac sulfide results in increased expression of PVT1 mRNA
CTD
PMID:12734198
NCBI chr 7:93,656,528...93,879,938
G
Ranbp1
RAN binding protein 1
increases expression
ISO
sulindac sulfide results in increased expression of RANBP1 mRNA
CTD
PMID:12734198
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:82,742,600...82,750,838
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
sulindac sulfide results in increased expression of RAP1GAP mRNA
CTD
PMID:12734198
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rb1
RB transcriptional corepressor 1
affects activity
ISO
sulindac sulfide affects the activity of RB1 protein
CTD
PMID:15694660
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Recql4
RecQ like helicase 4
decreases expression
ISO
sulindac sulfide results in decreased expression of RECQL4 mRNA
CTD
PMID:16184548
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
G
Reg1a
regenerating family member 1 alpha
decreases expression
ISO
sulindac sulfide results in decreased expression of REG1A mRNA
CTD
PMID:16184548
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:110,892,453...110,895,570
G
Rela
RELA proto-oncogene, NF-kB subunit
decreases activity
ISO
sulindac sulfide results in decreased activity of RELA protein
CTD
PMID:11912124 PMID:12085227
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rere
arginine-glutamic acid dipeptide repeats
decreases expression
ISO
sulindac sulfide results in decreased expression of RERE mRNA
CTD
PMID:12734198
NCBI chr 5:160,765,855...161,097,678
Ensembl chr 5:160,765,934...161,097,677
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
sulindac sulfide results in increased expression of RGS16 mRNA
CTD
PMID:16184548
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhoa
ras homolog family member A
multiple interactions
ISO
[sulindac sulfide results in increased activity of RHOA protein] which results in increased expression of THBS1 protein; RHOA protein promotes the reaction [sulindac sulfide results in increased expression of THBS1 protein]
CTD
PMID:18261746
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
sulindac sulfide results in decreased expression of RRM2 mRNA
CTD
PMID:12734198
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
G
Rrs1
ribosome biogenesis regulator 1 homolog
increases expression
ISO
sulindac sulfide results in increased expression of RRS1 mRNA
CTD
PMID:12734198
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
G
Serpinb5
serpin family B member 5
decreases expression
ISO
sulindac sulfide results in decreased expression of SERPINB5 mRNA
CTD
PMID:15897233
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpine1
serpin family E member 1
increases expression
ISO
sulindac sulfide results in increased expression of SERPINE1 mRNA
CTD
PMID:15897233
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Skp2
S-phase kinase associated protein 2
decreases expression
ISO
sulindac sulfide results in decreased expression of SKP2 mRNA
CTD
PMID:16184548
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slc25a1
solute carrier family 25 member 1
decreases expression
ISO
sulindac sulfide results in decreased expression of SLC25A1 mRNA
CTD
PMID:16184548
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a45
solute carrier family 25, member 45
increases expression
ISO
sulindac sulfide results in increased expression of SLC25A45 mRNA
CTD
PMID:12734198
NCBI chr 1:203,166,362...203,174,473
Ensembl chr 1:203,166,683...203,174,473
G
Slc3a2
solute carrier family 3 member 2
increases expression
ISO
sulindac sulfide results in increased expression of SLC3A2 mRNA
CTD
PMID:16184548
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:205,604,468...205,618,931
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
sulindac sulfide results in increased expression of SPRR1B mRNA
CTD
PMID:16184548
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sptbn1
spectrin, beta, non-erythrocytic 1
decreases expression
ISO
sulindac sulfide results in decreased expression of SPTBN1 mRNA
CTD
PMID:12734198
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Sqstm1
sequestosome 1
increases expression
ISO
sulindac sulfide results in increased expression of SQSTM1 mRNA
CTD
PMID:16184548
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
sulindac sulfide results in decreased expression of SREBF2 mRNA
CTD
PMID:16184548
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:113,663,202...113,720,848
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases expression
ISO
sulindac sulfide results in decreased expression of and results in decreased phosphorylation of STAT3 protein sulindac sulfide results in decreased expression of STAT3 mRNA
CTD
PMID:17566705
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stc2
stanniocalcin 2
increases expression
ISO
sulindac sulfide results in increased expression of STC2 mRNA
CTD
PMID:12734198
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Stk17b
serine/threonine kinase 17b
increases expression
ISO
sulindac sulfide results in increased expression of STK17B mRNA
CTD
PMID:16184548
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Syde1
synapse defective Rho GTPase homolog 1
increases expression
ISO
sulindac sulfide results in increased expression of SYDE1 mRNA
CTD
PMID:12734198
NCBI chr 7:11,032,931...11,038,917
Ensembl chr 7:11,032,898...11,039,869
G
Tfap2b
transcription factor AP-2 beta
increases expression
ISO
sulindac sulfide results in increased expression of TFAP2B mRNA
CTD
PMID:16184548
NCBI chr 9:29,282,703...29,312,568
Ensembl chr 9:21,786,258...21,814,520
G
Tff3
trefoil factor 3
decreases expression
ISO
sulindac sulfide results in decreased expression of TFF3 mRNA
CTD
PMID:16184548
NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054
G
Thbs1
thrombospondin 1
multiple interactions increases expression
ISO
[sulindac sulfide results in increased activity of RHOA protein] which results in increased expression of THBS1 protein; [sulindac sulfide results in increased phosphorylation of MAPK1 protein] which results in increased expression of THBS1 protein; [sulindac sulfide results in increased phosphorylation of MAPK3 protein] which results in increased expression of THBS1 protein; EGR1 protein affects the reaction [sulindac sulfide results in increased expression of THBS1 mRNA]; RHOA protein promotes the reaction [sulindac sulfide results in increased expression of THBS1 protein]; U 0126 inhibits the reaction [sulindac sulfide results in increased expression of THBS1 mRNA]; U 0126 inhibits the reaction [sulindac sulfide results in increased expression of THBS1 protein] sulindac sulfide results in increased expression of THBS1 mRNA; sulindac sulfide results in increased expression of THBS1 protein
CTD
PMID:16227405 PMID:18261746
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tk1
thymidine kinase 1
decreases expression
ISO
sulindac sulfide results in decreased expression of TK1 mRNA
CTD
PMID:16184548
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
G
Tmpo
thymopoietin
decreases expression
ISO
sulindac sulfide results in decreased expression of TMPO mRNA
CTD
PMID:16184548
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
ISO
sulindac sulfide results in decreased expression of TMSB4X mRNA
CTD
PMID:15292456
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667 Ensembl chr10:27,128,610...27,146,667
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein; [sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein; sulindac sulfide inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP3 protein]; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein]
CTD
PMID:10866999 PMID:20371263
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
sulindac sulfide results in increased expression of TNFRSF10A mRNA; sulindac sulfide results in increased expression of TNFRSF10A protein
CTD
PMID:15180942
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]]; BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]]; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP3 protein]; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]; TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP9 protein]
CTD
PMID:12203115
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
decreases expression
ISO
sulindac sulfide results in decreased expression of TP53 protein
CTD
PMID:9192825
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Trip4
thyroid hormone receptor interactor 4
increases expression
ISO
sulindac sulfide results in increased expression of TRIP4 mRNA
CTD
PMID:16184548
NCBI chr 8:66,351,861...66,439,679
Ensembl chr 8:66,353,248...66,439,774
G
Tspan8
tetraspanin 8
decreases expression
ISO
sulindac sulfide results in decreased expression of TSPAN8 mRNA
CTD
PMID:16184548
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
G
Tuba4a
tubulin, alpha 4A
decreases expression
ISO
sulindac sulfide results in decreased expression of TUBA4A mRNA
CTD
PMID:12734198
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
sulindac sulfide results in increased expression of TXNRD1 mRNA
CTD
PMID:16184548
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Uba7
ubiquitin-like modifier activating enzyme 7
decreases expression
ISO
sulindac sulfide results in decreased expression of UBA7 mRNA
CTD
PMID:16184548
NCBI chr 8:117,543,902...117,552,709
Ensembl chr 8:108,665,292...108,674,099
G
Ube2d1
ubiquitin-conjugating enzyme E2D 1
increases expression
ISO
sulindac sulfide results in increased expression of UBE2D1 mRNA
CTD
PMID:16184548
NCBI chr20:17,309,315...17,343,770
Ensembl chr20:17,309,315...17,342,295
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases activity increases expression
ISO
sulindac sulfide results in increased activity of UGT1A1 protein sulindac sulfide results in increased expression of UGT1A1 mRNA
CTD
PMID:17985343
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Upp1
uridine phosphorylase 1
increases expression
ISO
sulindac sulfide results in increased expression of UPP1 mRNA
CTD
PMID:16184548
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462
G
Vmp1
vacuole membrane protein 1
increases expression
ISO
sulindac sulfide results in increased expression of VMP1 mRNA
CTD
PMID:12734198
NCBI chr10:71,405,058...71,505,045
Ensembl chr10:71,405,452...71,505,007
G
Xrcc6
X-ray repair cross complementing 6
increases expression
ISO
sulindac sulfide results in increased expression of XRCC6 mRNA
CTD
PMID:12734198
NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:113,543,057...113,563,762
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
multiple interactions decreases expression
ISO
[sulindac sulfide results in decreased expression of YWHAE protein] which results in increased localization of BAD protein; PPARD protein affects the reaction [sulindac sulfide results in decreased expression of YWHAE protein]; sulindac sulfide promotes the reaction [BAD protein binds to YWHAE protein] sulindac sulfide results in decreased expression of YWHAE mRNA; sulindac sulfide results in decreased expression of YWHAE protein
CTD
PMID:17409426 PMID:18678619
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Akr1b1
aldo-keto reductase family 1 member B1
multiple interactions
ISO
sulindac sulfone binds to and results in decreased activity of AKR1B1 protein
CTD
PMID:25532697
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
multiple interactions
ISO
sulindac sulfone binds to and results in decreased activity of AKR1B10 protein
CTD
PMID:25532697
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akt1
AKT serine/threonine kinase 1
affects phosphorylation multiple interactions
ISO EXP
sulindac sulfone affects the phosphorylation of AKT1 protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein; [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AKT1 protein modified form
CTD
PMID:15570007 PMID:17908994
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alox15
arachidonate 15-lipoxygenase
multiple interactions increases expression
ISO
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [sulindac sulfone results in increased phosphorylation of ALOX15 protein]; GATA6 protein inhibits the reaction [sulindac sulfone results in increased expression of ALOX15 protein] sulindac sulfone results in increased expression of ALOX15 mRNA; sulindac sulfone results in increased expression of ALOX15 protein
CTD
PMID:11861401 PMID:16166323
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,060,412...55,068,874
G
Ar
androgen receptor
multiple interactions
ISO EXP
AR protein affects the reaction [sulindac sulfone results in decreased expression of KLK3 protein]; sulindac sulfone results in decreased expression of and results in decreased activity of AR protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of AR protein
CTD
PMID:14581372 PMID:17908994
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Bak1
BCL2-antagonist/killer 1
increases response to substance
EXP
BAK1 results in increased susceptibility to sulindac sulfone
CTD
PMID:18349538
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Casp3
caspase 3
multiple interactions increases activity
ISO
MAP2K1 protein inhibits the reaction [sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein]; sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein sulindac sulfone results in increased activity of CASP3 protein
CTD
PMID:11051267 PMID:14555707 PMID:15548677
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
sulindac sulfone results in increased activity of CASP8 protein
CTD
PMID:11559570
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO EXP
sulindac sulfone results in decreased expression of CCND1 mRNA; sulindac sulfone results in decreased expression of CCND1 protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of CCND1 protein
CTD
PMID:12392815 PMID:15188006 PMID:17908994
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
sulindac sulfone results in increased expression of CDKN1A mRNA; sulindac sulfone results in increased expression of CDKN1A protein
CTD
PMID:18593937
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
sulindac sulfone results in increased expression of CDKN1B mRNA; sulindac sulfone results in increased expression of CDKN1B protein
CTD
PMID:18593937
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Ctnnb1
catenin beta 1
multiple interactions increases expression decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] sulindac sulfone results in increased expression of CTNNB1 protein
CTD
PMID:10910034 PMID:11602670 PMID:12392815 PMID:14555707
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Egfr
epidermal growth factor receptor
multiple interactions increases ubiquitination increases phosphorylation decreases phosphorylation decreases expression
ISO EXP
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of EGFR protein]; Chloroquine inhibits the reaction [sulindac sulfone results in decreased expression of EGFR protein] sulindac sulfone results in increased ubiquitination of EGFR protein [Celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein; [Celecoxib co-treated with sulindac sulfone] results in decreased expression of EGFR protein modified form sulindac sulfone results in increased phosphorylation of EGFR protein sulindac sulfone results in decreased phosphorylation of EGFR protein
CTD
PMID:17908994 PMID:20332299
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
sulindac sulfone results in decreased expression of ERBB2 protein
CTD
PMID:20332299
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of ERBB3 protein]
CTD
PMID:20332299
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Esr1
estrogen receptor 1
decreases expression
ISO
sulindac sulfone results in decreased expression of ESR1 mRNA; sulindac sulfone results in decreased expression of ESR1 protein
CTD
PMID:16740773
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Gata6
GATA binding protein 6
multiple interactions decreases expression
ISO
GATA6 protein inhibits the reaction [sulindac sulfone results in increased expression of ALOX15 protein] sulindac sulfone results in decreased expression of GATA6 protein
CTD
PMID:11861401
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
sulindac sulfone binds to and results in decreased activity of GSTP1 protein
CTD
PMID:15300575
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hint1
histidine triad nucleotide binding protein 1
increases expression
ISO
sulindac sulfone results in increased expression of HINT1 mRNA; sulindac sulfone results in increased expression of HINT1 protein
CTD
PMID:18593937
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases activity increases expression
ISO
sulindac sulfone results in increased activity of HPGD protein sulindac sulfone results in increased expression of HPGD mRNA
CTD
PMID:19501039
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Il24
interleukin 24
increases expression
ISO
sulindac sulfone results in increased expression of IL24 protein
CTD
PMID:15713900
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:42,353,090...42,358,487
G
Klk1c10
kallikrein 1-related peptidase C10
multiple interactions decreases expression
ISO
AR protein affects the reaction [sulindac sulfone results in decreased expression of KLK3 protein]
CTD
PMID:11490238 PMID:14581372
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK3 protein]; MAP2K1 protein inhibits the reaction [sulindac sulfone results in increased cleavage of and results in increased activity of CASP3 protein]
CTD
PMID:15548677
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Map2k4
mitogen activated protein kinase kinase 4
multiple interactions
ISO
sulindac sulfone results in increased phosphorylation of and results in increased activity of MAP2K4 protein
CTD
PMID:11051267
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:15548677
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO
MAP2K1 protein inhibits the reaction [sulindac sulfone results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:15548677
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases activity
ISO
sulindac sulfone results in increased activity of MAPK8 protein
CTD
PMID:11051267 PMID:11278263 PMID:15970671
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
sulindac sulfone results in decreased expression of MMP7 protein
CTD
PMID:15725655
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
sulindac sulfone results in increased degradation of and results in decreased expression of NFKBIA protein
CTD
PMID:18059344
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Ngfr
nerve growth factor receptor
increases expression
ISO
sulindac sulfone results in increased expression of NGFR mRNA; sulindac sulfone results in increased expression of NGFR protein
CTD
PMID:17447067
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases activity increases expression
ISO
sulindac sulfone results in increased activity of NQO1 protein sulindac sulfone results in increased expression of NQO1 mRNA
CTD
PMID:17985343
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
sulindac sulfone results in decreased expression of PCNA protein
CTD
PMID:15570007
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pde2a
phosphodiesterase 2A
decreases activity multiple interactions
ISO
sulindac sulfone results in decreased activity of PDE2A protein sulindac sulfone binds to and results in decreased activity of PDE2A protein
CTD
PMID:10910034 PMID:11602670
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:155,813,180...155,915,434
G
Pde5a
phosphodiesterase 5A
multiple interactions decreases activity
ISO
sulindac sulfone binds to and results in decreased activity of PDE5A protein sulindac sulfone results in decreased activity of PDE5A protein
CTD
PMID:10910034 PMID:11602670
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
G
Pgr
progesterone receptor
decreases expression
ISO
sulindac sulfone results in decreased expression of PGR mRNA; sulindac sulfone results in decreased expression of PGR protein
CTD
PMID:16740773
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
ISO
sulindac sulfone results in increased expression of PPARA mRNA
CTD
PMID:11948457
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression
ISO
sulindac sulfone results in increased expression of PPARD mRNA
CTD
PMID:11948457
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]; PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA] sulindac sulfone results in increased expression of PPARG mRNA
CTD
PMID:11948457 PMID:14506281
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Prkg1
protein kinase cGMP-dependent 1
increases expression
ISO
sulindac sulfone results in increased expression of PRKG1 protein
CTD
PMID:11602670 PMID:16731751
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Psca
prostate stem cell antigen
increases expression
ISO
sulindac sulfone results in increased expression of PSCA mRNA
CTD
PMID:16949054
NCBI chr 7:108,483,974...108,492,098
Ensembl chr 7:106,595,284...106,609,746
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
EXP
sulindac sulfone results in decreased expression of PTGS1 mRNA alternative form
CTD
PMID:11375891
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions increases expression
ISO EXP
sulindac sulfone results in decreased expression of PTGS2 protein sulindac sulfone results in decreased expression of PTGS2 mRNA [Celecoxib co-treated with sulindac sulfone] results in decreased expression of PTGS2 protein; Celecoxib promotes the reaction [sulindac sulfone results in decreased expression of PTGS2 protein] [sulindac sulfone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone sulindac sulfone results in increased expression of PTGS2 mRNA
CTD
PMID:11118042 PMID:11375891 PMID:11948457 PMID:17908994
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization
ISO
sulindac sulfone affects the localization of RELA protein
CTD
PMID:18059344
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Sat1
spermidine/spermine N1-acetyl transferase 1
multiple interactions increases expression
ISO
[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]; PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA]
CTD
PMID:14506281 PMID:16262603
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Tnf
tumor necrosis factor
multiple interactions
EXP
Celecoxib promotes the reaction [sulindac sulfone results in decreased expression of TNF protein]
CTD
PMID:17908994
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases activity increases glucuronidation increases expression
ISO
sulindac sulfone results in increased activity of UGT1A1 protein UGT1A1 protein results in increased glucuronidation of sulindac sulfone sulindac sulfone results in increased expression of UGT1A1 mRNA
CTD
PMID:15843492 PMID:17985343
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of sulindac sulfone
CTD
PMID:15843492
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
increases glucuronidation
ISO
UGT1A4 protein results in increased glucuronidation of sulindac sulfone
CTD
PMID:15843492
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases glucuronidation
ISO
UGT2B7 protein results in increased glucuronidation of sulindac sulfone
CTD
PMID:15843492
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604
G
Vasp
vasodilator-stimulated phosphoprotein
increases phosphorylation
ISO
sulindac sulfone results in increased phosphorylation of VASP protein
CTD
PMID:16166323
NCBI chr 1:88,038,026...88,053,783
Ensembl chr 1:78,910,011...78,925,061
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
decreases expression
ISO
sulindac sulfone results in decreased expression of YWHAE protein
CTD
PMID:17409426
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all